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Magnetic resonance imaging (MRI) is a widely used non-invasive imaging technique, 
with rich contrast for interrogation of tissue physiology and pathology. MRI can be 
used to examine hemodynamic conditions like perfusion and oxygenation qualitatively 
and quantitatively. This dissertation reports new techniques that employ dynamic 
imaging and quantitative susceptibility mapping (QSM) to overcome technical 
challenges for improved MRI perfusion imaging and oxygenation quantification. 
Perfusion imaging after gadolinium contrast agent administration is a common 
clinical practice, where dynamic MRI technique is used to track contrast bolus. It is 
desirable to have high temporal resolution to capture blood dynamics, as well as high 
spatial resolution to depict small lesions. Unfortunately, these requirements are limited 
by hardware and physiological conditions. In this dissertation, a dynamic MRI 
technique was realized, using fast spiral acquisition and a constrained image 
reconstruction algorithm, to achieve high temporal-spatial resolution for liver 
perfusion imaging. 
Tissue susceptibility provides unique contrast in MRI. Recent development of 
QSM technique has been applied in various clinical applications. In this dissertation, 
 the dynamic imaging method was extended to multi-echo acquisition and combined 
with QSM to map gadolinium contrast agent concentration during the first passage for 
cerebral perfusion mapping. 
Blood oxygenation is determined by the amount of deoxyhemoglobin in red blood 
cell. Magnetic susceptibility of deoxyhemoglobin is a source of MR contrast for 
imaging oxygenation. This dissertation reports correction schemes in both data 
acquisition and image reconstruction of QSM for improved blood oxygenation 
quantification.
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CHAPTER 1  
INTRODUCTION 
MRI is a versatile imaging modality used in a wide range of clinical realms. Since its 
early invention, MRI has been used to imaging vessel physiology and blood flow. 
Perfusion MRI is a technique to investigate blood delivery to capillary beds in 
biological tissues. It involves three categories of imaging method: dynamic contrast 
enhanced (DCE) MRI, dynamic susceptibility contrast (DSC) MRI and arterial spin 
labeling (ASL). DCE-MRI and DSC-MRI use extraneous contrast agent and benefit 
from increased SNR from elevated blood contrast. In the first passage of contrast 
agent, vessels and tissues have a peak enhancement with the contrast arrival. This peak 
enhancement may vary across different tissues by its arrival time, amplitude, widths 
and shape. The enhancement pattern provides a qualitative and quantitative 
understanding of the tissue perfusion that can help diagnosis of diseases such as stroke 
and tumor. 
The first passage of contrast agent only spans tens of second if not shorter. This 
short time window poses great challenges to capturing the enhancement dynamics 
accurately. Temporal resolution, spatial resolution and volume coverage bring 
conflicting scan requirements for dynamic MRI. In addition, hardware limits, 
physiological constraints, respiratory and cardiac motions pose difficulties for high 
spatial-temporal resolution imaging of contrast agent first passage. To overcome these 
difficulties, signal acquisition and image reconstruction innovations have been sought 
for to accelerate dynamic MRI. Techniques are developed to exploit the redundancy in 
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spatial and temporal information, among which, non-Cartesian sampling, parallel 
imaging, compressed sensing and constrained reconstruction are shown to be 
successful. Each acceleration scheme is tuned to fit certain applications and can be 
combined with other schemes to achieve further acceleration. 
Blood oxygenation is an important physiological parameter. The susceptibility 
effect of deoxyhemoglobin in the blood can be used to quantify venous oxygenation. 
When a vessel is approximated as a long cylinder, the blood susceptibility is 
proportional to its induced phase shift, with knowledge of the angle between the vessel 
and magnetic field. This limits the available vessels for measurement and prevent from 
mapping global oxygenation. Mapping susceptibility without geometric constraints is 
desired. Recently developed quantitative susceptibility mapping serves to this need. 
QSM has been successful in static tissues but needs further investigation for mapping 
blood susceptibility. Flow induced extra phase needs to be considered in both 
acquisition and reconstruction for accurate blood susceptibility mapping. 
1.1 Summary of Contributions 
In this dissertation, three techniques for interrogating tissue perfusion and quantitating 
oxygenation are developed. First, a fast dynamic imaging framework is developed to 
allow high temporal frame rate dynamic contrast enhanced liver imaging. Second, this 
dynamic imaging technique is extended for multi-echo acquisition and combined with 
quantitative susceptibility mapping for contrast agent quantification in cerebral 
perfusion imaging. Thirdly, a correction scheme is developed to account for blood 
flow induced phase error in quantitative susceptibility mapping, permitting more 
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accurate venous oxygenation quantification. 
1. Dynamic Contrast Enhanced Liver Imaging. Chapter 3 presents a fast dynamic 
imaging technique that achieves sub-second temporal frame rate for dynamic 
contrast enhanced liver imaging. Spiral trajectory with golden angle view order 
and fat suppression was designed for data acquisition. Temporal Resolution 
Acceleration with Constrained Evolution Reconstruction (TRACER) was 
developed for reconstruction. TRACER utilizes the prior information from 
previous frame and updates the dynamic change using information from single 
spiral sampling. Its temporal tracking ability is tested in phantom studies. The high 
temporal update gives exquisite depiction of vessel and tissue enhancement 
patterns, which allows confident qualitative assessment of liver perfusion. 
2. Dynamic Susceptibility Mapping. Chapter 4 proposes a new technique to measure 
gadolinium contrast agent concentration for cerebral perfusion imaging. A multi-
echo spiral readout sequence is developed. All-echo flow compensation gradients 
are designed. Time resolved phase data are reconstructed to compute dynamic 
susceptibility maps. Artery and tissue concentration time curves are obtained 
directly from the susceptibility maps. These time curves are used to generate 
cerebral blood flow and cerebral blood volume maps. Contrast concentration 
measurement from susceptibility avoids the assumption of linear relaxivity-
concentration and requirement for tissue relaxivity in T2* based method. The 
measured cerebral blood flow matches that obtained from arterial spin labeling 
technique. 
3. Venous Oxygenation Quantification. Chapter 5 reports an improved quantitative 
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susceptibility mapping technique to measure blood susceptibility for oxygenation 
quantification. The relationship between MR phase signal and echo time is 
modeled in the presence of flow. Gradient moment nulling was applied on each 
gradient axes for all echoes. An adaptive-quadratic fit that better models the blood 
voxel phase TE relationship was proposed. Phantom experiments demonstrate 
improved susceptibility mapping with adaptive-quadratic fit. In vivo studies show 
better visualization of the veins and improved oxygenation values.
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CHAPTER 2  
BACKGROUND 
MRI stems from nuclear magnetic resonance (NMR). Interaction of nuclear spins with 
an external magnetic field results in spin precession about the field direction, which 
induces signals that could be detected for imaging. The dominant nucleus in MRI is 
hydrogen proton which accounts for two thirds of the body weight. By manipulating 
the magnetic field, detecting the bulk precession and reconstructing the signal, organs 
and tissues could be imaged. In this chapter, the MRI physics is briefly introduced, 
several image reconstruction methods are presented, and biological aspects related to 
this dissertation are discussed. 
2.1 MRI Physics 
2.1.1 Signal generation 
When a proton spin is placed in an external magnetic field  , its magnetic moment   
rotates along the field direction. This spin precession phenomenon can be described by 
Eq [2.1].  
 
  
  
        [2.1] 
The   factor, called gyromagnetic ratio depends on the nucleus and         
   
   
 
  , or              for proton. To generate detectable MR signal, a 
radio-frequency (rf) field   is applied to tip the proton spin away from    
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direction. The frequency of    has to match the gyromagnetic frequency for effective 
polarization (on resonance). The    field is only applied for a finite time, tipping the 
spin away from    direction for certain degree, called flip angle. This process is 
termed as “rf excitation”. The rf pulses are usually designed to excite a certain slab of 
tissue and the detected signal is from this section of the imaging object.  
The bulk magnetization   is used to describe an ensemble of spins. After rf 
excitation, spin isochromats try to align with the    field due to the energy exchange 
of spins and their surroundings. The longitudinal magnetization    recovers to  , 
which is called spins-lattice relaxation. The inverse of the rate of change, called spin-
lattice relaxation time T1, varies among different tissues. The spin-spin interaction 
causes decay of transverse magnetization   . The spin-spin relaxation time T2 also 
varies in different tissues. Putting polarization and relaxation together, the bulk 
magnetization after rf excitation can be described using Bloch equation: 
 
  
  
        
 
  
(     )  
 
  
    [2.2] 
The transverse magnetization    has a frequency corresponding to the 
gyromagnetic ratio. This radio-frequency transverse magnetization generates signal to 
be detected in MRI. 
2.1.2 Spatial encoding 
A linear gradient field ( ) is used to encode spins at different positions. In each 
location, the spins see a local magnetic field that slightly deviates from   , thus 
having different precession rates. The tissue at a particular position is differentiated by 
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the frequency of the signal it generates. Three sets of coils are used to create ( ). The 
maximum gradient amplitude ant slew rates determines the scan time and are 
important factors to evaluate the scanner performance. With the help of spatial 
encoding, MR signal equation is formulated in Eq [2.3], 
 
 ( )  ∫ ( )          [2.3] 
Here   is proton density including the relaxation effect,   is spatial coordinates, 
 ( )   ∫  ( )
 
 
   is the so called k-space coordinates. Notice the acquired signal 
 ( ) is the spatial Fourier transform of the imaging object  ( ). The spatial 
frequency domain or k-space is traversed by adjusting gradient field ( ). Different 
sampling strategies to traverse the k-space can be designed by using different ( ). 
2.1.3 Signal detection and acquisition 
The transverse magnetization is detected using receiver rf coils. Time varying     
generates magnetic flux and current in receiver coils. The electric signal is amplified, 
digitized, demodulated and filtered. Usually an array of receiver coils is used to reach 
uniform coverage of the object. Each array element m has a distinct complex 
sensitivity   . The sensitivity is determined by the position and phase of the coil 
element. For a coil array with    elements, the signal equation for each coil is 
 
  ( )  ∫ ( )  ( ) 
           (      ) [2.4] 
The coil images   ( ) are combined to form the final image. 
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The transverse magnetization     experiences T2 decay effect during data 
acquisition. The imperfect magnetic field creates additional phase dispersion and 
decay. The combined decay rate is quantified as T2
*
. There are two types of signal 
acquisition method: spin echo and gradient echo. Spin echo acquisition employs two rf 
pulses: a π/2-pulse followed by a π-pulse. The π-pulse reversed any field 
inhomogeneity induced dephasing and forms T2 decay signal envelop. Gradient echo 
acquisition only has an α-pulse and forms T2
*
 decay signal envelop. 
In gradient echo sequence, after each α-pulse, the longitudinal magnetization 
recovers to some degree before next pulse. After a few continuously applied rf pulse, 
the transverse magnetization reaches steady state: 
 
          
         
             
 [2.5] 
At the end of each rf pulse, if the transverse magnetization is completely dephased or 
spoiled by applying a big gradient, the sequence is called spoiled gradient echo 
(SPGR) sequence. In this dissertation, SPGR is the primary type of sequence to use. 
To satisfy the Nyquist theorem, the k-space sampling interval has to be dense 
enough to completely recover the object. The minimal sampling interval Δk = 1/FOV, 
where FOV is the imaging field of view. Violation of the sampling theorem can result 
in aliasing artifact. 
2.1.4 Sampling trajectory 
By manipulating the gradient field, different sampling strategies can be achieved for k-
space sampling. The most common way is Cartesian sampling, where the k-space is 
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sampled line by line. One k-space line is acquired before stepping the phase encoding 
gradient in the following TR. A typical pulse sequence and sampling trajectory for 
Cartesian sampling is shown in Figure 2.1. 
 
Figure 2.1 Cartesian Sampling 
Pulse sequence diagram and k-space sampling scheme in Cartesian sampling. 
Non-Cartesian trajectories like radial or spiral has higher k-space sampling 
efficiency. In radial sampling, the k-space is traversed by a set of radial spokes. Each 
spoke is a k-space line as in Cartesian sampling but they all cross the center of k-space 
so carrying the low frequency information. Figure 2.2 shows the pulse sequence 
diagram and k-space trajectory in radial sampling. In spiral sampling, each spiral leaf 
spreads from the k-space center and covers a big portion of the k-space. By adjusting 
the shape of the spiral, different density of k-space coverage could be achieved. Figure 
2.3 shows the pulse sequence diagram and k-space trajectory of a spiral sampling. 
Both radial and spiral sampling are robust to motion and as they sample the center of 
k-space frequently. They also give flexibility for view ordering when used in dynamic 
imaging techniques. 
Gx
Gy
Gz
rf
kx
ky
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Figure 2.2 Radial Sampling 
Pulse sequence diagram and k-space trajectory in radial sampling. 
 
Figure 2.3 Spiral sampling 
Pulse sequence diagram and k-space trajectory in spiral sampling. 
Non-Cartesian sampling is sensitive to gradient imperfections and magnetic field 
inhomogeneity. Care must be taken when designing and implementing non-Cartesian 
pulse sequence. Post-processing correction maybe needed to obtain artifact free 
images. 
Gx
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kx
ky
Gx
Gy
Gz
rf
kx
ky
 11 
2.2 Image Reconstruction 
For Cartesian sampling that satisfies Nyquist theorem, image reconstruction could be 
as simple as a discrete Fourier transform. With more complicated acquisition 
strategies and parallel imaging, dedicated image reconstruction beyond simple Fourier 
transform is needed. This section gives an overview of non-Cartesian Fourier 
transform, parallel imaging and dipole inversion for susceptibility mapping. Lastly, 
iterative reconstruction is discussed. 
2.2.1 Non-uniform Fourier transform 
In non-Cartesian sampling, acquired k-space data is not uniformly distributed on 
rectangular grid. The data is gridded to rectangular points for Fourier transform. 
A flow chart of the gridding steps is shown in Figure 2.4. 
 
Figure 2.4 Gridding steps 
The non-Cartesian data is first weighed by their density and then interpolated onto 
grids. The rectangular k-space data is Fourier transformed. Then roll-off correction is 
performed to get the final image.  
Firstly, the non-Cartesian data is weighed by a density function. The density 
weighting is inverse correlated with the density of the sampled data. For example, in 
radial sampling, the density is proportional to the radius of the k-space sampled point. 
Density 
weighting
Non-
Cartesian
data
Interpolation
Fourier 
Transform
Roll-off
correction
Recon 
Image
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In the next step, non-Cartesian points are interpolated onto rectangular grids by 
convolving with a Kaiser-Bessel kernel. An appropriate kernel size is chosen and 
usually the gridding size corresponds to two times the FOV. The Cartesian grid k-
space data is Fourier transform to obtain an image. This image is cropped to the 
original size to get rid of residual artifacts outside the FOV. Finally a roll-off 
correction is applied, where the intermediate image is divided by Fourier transform of 
the convolving kernel to get the final reconstructed image. 
2.2.2 Parallel imaging 
As previously mentioned, most receiver coils are arrays of coil elements. Each 
element covers a distinct part of the body and exhibits its own coil sensitivity. 
Traditionally, all coil images are combined together to get the final image. Due to the 
need for fast imaging application, parallel imaging has been developed where the 
correlation among different coils are used to accelerate the data acquisition for fast 
imaging. There are two categories of parallel imaging technique: k-space based 
method and image space based method. 
In k-space based method, coil sensitivities are not known but implicitly used as k-
space convolution kernels. A typical method in this category is GeneRalized 
Autocalibrating Partially Parallel Acquisitions (GRAPPA). Multiplication of image 
and coil sensitivity is equivalent to convolution of their corresponding k-space 
representation. As the coil sensitivity is usually very smooth, its k-space 
representation, or k-space convolution kernel is narrow and focal. Each k-space point 
can be reformatted as a weighted average of its surrounding points and the points from 
other coils. The weightings could be calibrated from a fully sampled k-space region 
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and used to reconstruct k-space region that is not acquired. 
In image space based method, known coil sensitivities are directly used to exploit 
data redundancy. A typical method in this category is SENSitivity Encoding (SENSE). 
Figure 2.5 shows the concept of SENSE in a two-coil example.  
 
Figure 2.5 principle of sensitivity encoding 
The aliased coil image is a weighed sum of voxels from the original image. The 
weighting is the coil sensitivity. 
Two voxels marked by yellow and red have signal intensity of    and   . The coil 
+ +
Image
Coil 
Sensitivity
Coil Image
Aliased 
Coil Image
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sensitivity of the corresponding voxel in the two coils are    ,     and    ,     
respectively. The fully sampled coil image is the original image weighted by the coil 
sensitivity. In accelerated imaging, only half of the k-space lines are acquired. The 
corresponding coil image is aliased. One voxel in this aliased image is the sum of two 
voxels in the “true” coil images. With known coil sensitivities, there are two 
unknowns    and    and two measurements    and   . Solving a linear equation 
would recover    and   . 
 
{
                   
                   
 [2.6] 
A more general form of this linear system is: 
 
[
   
 
    
]  [
         
   
           
] [
   
 
    
] [2.7] 
When the system is over-determined (    ), and the coils sensitivities are distinct 
(coil sensitivity matrix is well conditioned), an accurate estimation of the voxel image 
content could be obtained. In this dissertation, the proposed constrained reconstruction 
method is image based parallel imaging that rooted from SENSE. 
2.2.3 Susceptibility mapping 
Magnetic susceptibility indicates the degree of magnetization of a material in response 
to an applied magnetic field. Many biological relevant materials like iron, calcium and 
gadolinium have different susceptibility. It provides an addition contrast to T1 and T2. 
Quantifying susceptibility opens a new venue to investigate tissue physiology and 
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pathology. 
The longitudinal magnetic field produced by a material with susceptibility   can 
be determined by convolving the susceptibility distribution with the dipole response 
 
   ( )  
 
  
∫ (  )
        
|    | 
     [2.8] 
where    ( ) is the field change,   is the spatial coordinate,   is the angle 
between      and   . By measuring    ( ), the susceptibility distribution   can 
be computed by de-convolution of the dipole kernel. The    ( ) field generated 
from susceptibility source does not change with time. Considering this local field 
change, the MR signal equation becomes:  
 
 ( )  ∫ ( )      ( )           [2.9] 
The field change results in a phase shift in the image that is proportional to TE. By 
measuring the phase and performing a linear fit,   ( ) could be obtained. 
The obtained   ( ) is the total field change that induced by tissue as well as air, 
bone and fat which has much higher susceptibility. These susceptibility sources create 
a big background magnetic field that needs to be removed to unveil the local field that 
produced by tissue of interest. 
After the background removal step, a dipole de-convolution algorithm is applied to 
de-convolve   from Eq [2.9]. The dipole kernel 
        
|    | 
 has a zero value cone 
surface which makes the de-convolution under-determined problem. Prior knowledge 
needs to be incorporated to perform this de-convolution. Robust, efficient and accurate 
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de-convolution algorithm is still a hot topic under research. 
2.2.4 Iterative reconstruction 
In accelerated MRI, non-Cartesian sampling and parallel imaging are often combined 
to achieve high acceleration factor. In 2.3.2, the reconstruction procedure of SENSE is 
introduced. In that example, the Cartesian under-sampling in k-space results in a nice 
aliasing pattern that could be used to form a linear system to reconstruct the original 
image. For non-Cartesian sampling, the aliasing in image space does not have an 
explicit representation from the image and coil sensitivities. Direct un-aliasing is not 
readily available.   
Iterative reconstruction can be used in this scenario. The MR signal equation  
 
  ( )  ∫ ( )  ( ) 
           (      ) [2.10] 
can be reformulated in a linear system point. Let   denotes point-wise matrix 
multiplication, and   denotes Fourier transform operator, the signal equation 
becomes 
 
    (     )    (      ) [2.11] 
or 
 
   (   ) [2.12] 
where   [         ], and   [         ]. The non-Cartesian sampling could 
also be treated as a linear operator  , which is a projection function in k-space. Then 
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the signal equation becomes: 
 
    (   )   ( ) [2.13] 
When   is equally spaced Cartesian projection, E could be directly inversed. 
When    is a non-Cartesian projection, multiply both side of the equation with    to 
make the system symmetric positive-definite. 
 
                  (   ) [2.14] 
Image   could be solved iteratively using conjugate gradient algorithm. 
In many MR reconstruction problems, the mathematic formulation is a linear or a 
nonlinear system based on the physical modeling of a forward problem. In the SENSE 
reconstruction, the forward problem is MR signal equation. In susceptibility mapping, 
the forward problem is convolution of dipole kernel with the susceptibility 
distribution. The commonality of these problems is the high dimension of unknowns 
and series of operations involved in the model. Iterative reconstruction is used in these 
situations. It is worth noting that the initial guess and the stopping criteria are 
important for iterative reconstruction. When the system is under-determined, 
regularization is needed. 
2.3 Contrast Agent 
Contrast agents are widely used in MRI to increase the SNR of blood and as a 
biomarker for quantitative evaluation of hemodynamics. For the past twenty years, 
gadolinium chelate contrast agent has been widely used in MR angiography, dynamic 
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contrast enhanced MRI and perfusion MRI. This section discusses about the physics 
property of gadolinium contrast agent and its usage in different imaging applications. 
2.3.1 Contrast enhancement 
Gadolinium (Gd) contrast agent is a Gd
3+ 
compounds with seven unpaired electrons. 
The Gd
3+ 
based molecules can bind free water and increase the effective relaxation 
rate of the surrounding water. Presence of contrast agent in the blood can greatly 
reduce both the longitudinal relaxation time T1 and transverse relaxation time T2 of 
blood. This effect is determined by the relaxivity r1 and r2 of the contrast agent. The 
relationship between relaxation time, relaxivity and contrast agent concentration is 
given by: 
 
 
  
 
 
   
     [2.15] 
 
 
  
 
 
   
     [2.16] 
Here     and     are relaxation time without contrast agent and C is the contrast 
agent concentration. The T1 shorting effect is usually applied in T1 weighted contrast 
enhanced MRI where the blood signal will be boosted dramatically to give good 
contrast to noise (CNR) of the blood. The T2 shorting effect is used in dynamic 
perfusion MRI for quantitative measurement of the contrast agent concentration. 
Besides relaxation effect, gadolinium contrast agent has a high susceptibility. The 
susceptibility of gadolinium is proportional to its concentration. Quantifying the 
susceptibility can provide contrast agent bio-distribution, which is an important 
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indicator of tissue physiology and hemodynamics. 
2.3.2 Timing and quantification 
Contrast agent is usually intravenous injected into a vein. It is mixed with blood in the 
heart and pumped to arterial supplied tissue. The contrast arrival time, enhancement 
peak amplitude and duration depend on the local hemodynamic property. Thus the 
enhancement pattern carries important pathophysiological information. 
The timing of contrast agent is crucial in applications where arterial and portal 
venous enhancement needs to be differentiated. In the first passage, there is a time 
window called arterial phase, when only the arteries are enhanced. A couple of 
seconds after arterial phase is the venous phase when veins get enhanced. In imaging 
of arterial malfunction, venous enhancement will overwhelm or cover the arteries and 
affect the diagnosis. Obtaining arterial phase is especially import in liver imaging. 
Liver has dual blood supply, the hepatic artery and portal vein. Normal liver 
parenchyma receives 75% blood supply from portal vein, while liver tumor receives 
most of its blood supply from hepatic artery. To obtain the arterial phase when only 
hepatic artery enhances is crucial in identification of liver tumors. Furthermore, 
different liver tumor has different enhancement patterns. Liver enhancement curves 
provide important information on categorizing different tumors. 
Quantification of contrast agent is also essential for many applications including 
perfusion MRI. Quantitative or semi-quantitative quantification of contrast agent 
could be determined from the change of blood T1 and T2 values pre- and post- contrast 
administration. Quantification requires contrast agent time curves that acquired from 
either T1 or T2 weighed sequences. T1 weighed dynamic contrast enhanced MRI is 
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used to investigate tumor activity. k
trans
, the volume transfer coefficient between the 
blood pool and the extracellular extravascular space, is usually computed as an 
indication of tumor micro-vascular permeability. In cerebral perfusion imaging, the 
contrast agent time courses in the supplying artery and capillaries can be used to 
determine cerebral blood volume and cerebral blood flow when the blood brain barrier 
is intact.  
Extracting quantitative time resolved information of contrast agent first pass has 
great clinical importance and drives the development of fast MRI technique described 
in this dissertation. 
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CHAPTER 3  
DYNAMIC CONTRAST ENHANCED LIVER MRI 
Time-resolved imaging is crucial for the accurate diagnosis of liver lesions. Current 
contrast enhanced liver MRI acquires a few phases in sequential breath-holds. The 
image quality is susceptible to bolus timing errors, which could result in missing the 
critical arterial phase. This impairs the detection of malignant tumors that are supplied 
primarily by the hepatic artery. Additionally, the temporal resolution may be too low 
to reliably separate the arterial phase from the portal venous phase. In this study, a 
method called Temporal Resolution Acceleration with Constrained Evolution 
Reconstruction (TRACER) was developed with 3D volume coverage and high 
temporal frame rate. Data is acquired using a stack of spirals sampling trajectory 
combined with a golden ratio view order using an 8-channel coil array. Temporal 
frames are reconstructed from vastly under-sampled data sets using a nonlinear inverse 
algorithm. Numerical and phantom experimental validation is presented. Preliminary 
in vivo results demonstrate high spatial resolution dynamic 3D images of the whole 
liver with high frame rates, from which numerous sub-arterial phases could be easily 
identified retrospectively. 
3.1 Introduction 
Multi-phase contrast enhanced magnetic resonance imaging is important for assessing 
liver function and characterizing liver lesions (1-7). The temporal pattern of 
enhancement may enable the specific characterization of lesions thereby avoiding 
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biopsy. It is necessary to distinguish the arterial supply from the portal venous supply 
to lesions and to visualize the perfusion and interstitial distribution of the gadolinium 
contrast agent in the liver parenchyma. In current liver MRI protocols, typically five 
phases are acquired: pre-contrast, arterial phase, portal venous phase and two delayed 
phases. High 3D spatial resolution is needed for the detection of smaller lesions, for 
which curative therapies can be most effective. Acquisition timing needed to capture 
the contrast bolus may be actuated using fluoroscopic triggering (8), using a delay 
derived from a prior test bolus or using a fixed timing delay. This introduces an 
operator dependence that makes it difficult to guarantee capturing the optimal arterial 
phase in every patient. An incorrect time delay between the injection and the start of 
imaging may lead to the loss of the arterial phase and may create a mixture of pre-
contrast, arterial and/or portal venous phases. Since liver diseases can affect the 
vasculature heterogeneously, the optimal timing may also vary with patients and 
lesions. This indicates that dynamic 3D CE MRI exam should further resolve the 
arterial phase into multiple sub-phases for accurate diagnosis of liver lesions (9). Even 
with parallel imaging, a typical 3D acquisition with adequate spatial resolution is over 
10 s, which is not adequate for resolving arterial sub-phases.  
In this study, a method called Temporal Resolution Acceleration with Constrained 
Evolution Reconstruction (TRACER) is developed based on a real time 2D radial 
technique recently proposed by Uecker et al.(10). TRACER samples k-space with a 
3D stack of variable density spirals to achieve a high temporal frame rate with whole 
volume coverage. We aim to validate the temporal tracking accuracy of TRACER and 
assess its advantages when applied to contrast enhanced liver MRI over the traditional 
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multi-phase imaging technique. 
3.2 Algorithm 
The concept of TRACER is to enforce image fidelity to the sampled data of the 
current time frame therefore minimizing temporal footprint, while maintaining image 
quality by imposing consistency with the previous image frame. Specifically, we 
illustrate here how TRACER reconstructs one temporal frame each time one spiral 
leaf is sampled across all slice encodes in stacked spiral 3D acquisition. Initially, a 
high quality base frame is formed from a fully sampled dataset, preferably using data 
without contrast enhancement, after which subsequent 3D volumes are reconstructed 
from highly under-sampled stack of spiral trajectories by limiting the amount of 
change that can occur in the images from one temporal frame to the next. Furthermore, 
the coil sensitivities are assumed to be changing during the scan and are thus 
considered as unknowns. This data reconstruction process is based on the nonlinear 
inverse algorithm proposed by Uecker et al. (11,12) where both image content and coil 
sensitivities can be jointly estimated. The 3D spoiled gradient echo signal equation is 
written as: 
 
          (     )    (  ) [3.1] 
where both the image    and the coil sensitivities    are unknown. All symbols are 
defined in Table 3.1. 
A solution xn at time frame n can be obtained iteratively. This involves linearizing 
the signal encoding function En around the current guess xn,m : 
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      (   )          (   ) [3.2] 
where xn,m is the solution of the (m – 1)
th
 iteration and dxn,m is the update calculated in 
the m
th
 iteration. 
Table 3.1 Symbols used in TRACER 
n time index 
m current iteration number 
yn k-space measurement at time n 
n unknown image content at time n 
En signal encoding function at time n, which maps the image n and the coil 
maps cn,j to the corresponding k-space yn 
Nc number of coils 
cn,j unknown coil sensitivity maps at time n, with j = 0, ..., Nc – 1 
xn vector (n, cn,0, cn,1 , … , cn,Nc-1) 
Pn k-space projection onto the sampling trajectory corresponding to time 
frame n 
F Fourier transform operator 
PFOV projection onto the field of view 
xn,m estimated solution of xn at the (m – 1)
th
 iteration 
dxn,m solution update for xn calculated in the m
th
 iteration 
 
An updated solution xn,m+1 is xn,m + dxn,m. Eq [3.2] can be solved using the following 
minimization: 
 
   ‖       (   )     (     (   ))‖
 
 [3.3] 
By adding a limited regularization term to Eq [3.3], the solving process becomes the 
well-known Levenberg-Marquardt (LM) algorithm or Iteratively Regularized Gauss-
Newton Method (IRGNM) (13-15). In the LM algorithm, a term n,m||dxn,m||
2
 is added 
to Eq [3.3]. This constrains the solution of the current iteration to be close to that of 
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the previous iteration. Then the problem becomes:  
 
     ‖      (   )     (     (   ))‖
 
    ‖    ‖
 
 [3.4] 
In the IRGNM algorithm, a term n,m||xn,m + dxn,m – xn,0||
2
 is added to Eq [3.3]. This 
constrains the solution of the current iteration to be close to the initial guess xn,0. Then 
the problem becomes: 
 
     ‖      (   )     (     (   ))‖
 
    ‖             ‖
 
 
[3.5] 
In both algorithms, n,mis reduced by half in each iteration (13-15). In preliminary 
testing, these two algorithms were compared to select an appropriate solver for the 
remainder of the reconstructions. 
The minimization in Eq [3.5] is a linear problem solved using a conjugate gradient 
solver. As coil sensitivities vary smoothly in space, the high spatial frequency 
components are constrained by adding a weighting matrix W to cn (11). In this work, 
the iteration was stopped when ||dxn,k|| > ||dxn,k-1|| and xn,k-1 was taken to be the 
reconstructed image at time point n, ie, xn = xn,k-1. The final reconstructed image is 
xnn(∑ cn,i
2
) as in (11). In dynamic imaging, the initial guess xn,0 is taken to be the 
reconstructed image xn-1 at time point n – 1. This algorithm is applied in situations 
where the difference between successive time points is sufficiently small such that the 
image update dxn,m can still be found despite the high under-sampling. In TRACER, 
we applied this algorithm to a 3D stack of spirals sampling method using golden ratio 
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updating. A single spiral leaf yn (acquired for each slice encoding) is used to update a 
3D volume xn. 
3.3 Data Acquisition  
A 3D fast spoiled gradient echo stack of spirals sequence with partial Fourier slice 
encoding is used for data acquisition (16). A spectrally selective inversion pulse 
combined with a segmented view order is employed to provide fat suppression 
(3,16,17). For a fully sampled kx-ky plane using 48 spirals, this spiral trajectory has a 
variable density such that the k-space is oversampled two-fold in the center while 
under-sampled by a factor of 0.7 at the edge (18,19). Consecutive spiral leafs are 
rotated by the golden ratio angle of 220° (20,21) such that each new spiral leaf is 
sampling a substantially different part of k-space compared to the immediately 
preceding leaf. For each spiral leaf, a full set of slice encodings (partially encoded) is 
acquired.  
3.4 Image Reconstruction 
A fully sampled k-space, consisting of 48 leaves, can be acquired before the arrival of 
contrast agent and used to reconstruct a pre-contrast volume (x0) which serves as the 
initial guess x1,0 for the reconstruction of the first dynamic frame. For the 
reconstruction of x0, the initial guess x0,0 is taken to be a matrix of ones for and a 
matrix of zeros for each cj (10). A scaling factor λ is calculated such that ||F
-1
(λy)||  
||F
-1
P0F(I)||, where I is a vector containing an image for each coil that has all pixels set 
to one. This λ is used to rescale all raw data y in the remainder of the reconstruction, 
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which in preliminary testing was found to ensure good convergence. The parameter 
0,0 needed in the LM algorithm is estimated by requiring that ||(dE/dx(x0,0))
H
 
dE/dx(x0,0)I|| × 10  ||0,0I||. For the under-sampled reconstructions of the successive 
time frames n > 0, the parameter n,0 is selected differently. First,1,0 is chosen to 
satisfy ||(dE/dx(x1,0))
H
 dE/dx(x1,0)σ||  ||1,0I|| while n,0 is set equal to this 1,0 for all 
other time frames n > 1. Again, this selection of the solver parameter was found to 
provide good convergence in preliminary testing. In the calculations, the damping 
factordecreases as follows: n,m = n,m-1/2. Reconstructed images are temporally 
filtered using a median filter (window size 5) to eliminate time dependent residual 
spiral artifacts. Solving Eq [3.4] using the conjugate gradient method requires gridding 
each coil image to a spiral k-space followed by gridding it back to image space. This 
process can be simplified by convolving the image with the point spread function of 
the sampling trajectory (22). Here a Kaiser-Bessel kernel width of 6 and oversampling 
factor of 3 were used. A smaller kernel width or oversampling factor was, in 
preliminary testing, found to result in appreciable accumulated error through the 
iterations due to errors in approximating the gridding-regridding operation with a 
convolution. The shape parameter of the Kaiser-Bessel kernel is computed according 
to Beatty et al. (23). All reconstruction parameters (the raw data scaling factor λ, and 
the solver parametern,m) were determined from the acquired raw data in the same 
manner for all numerical, phantom and in vivo experiments. In some experiments with 
possible contrast enhancement in the fully sampled dataset (constructed from the first 
48 spiral leaves), the dynamic reconstruction was started from the 48
th
 spiral leaf, but 
run backwards in time to the 1
st
 spiral leaf. This allowed obtaining the early 
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unenhanced frames, from which the reconstruction was then performed normally in 
the forward direction. 
3.5 Temporal Footprint 
3.5.1 Experiment design 
The temporal footprint of a single image in dynamic imaging may be defined as the 
temporal interval from which raw data is used for the reconstruction of that image 
(24). As TRACER updates the current frame with the raw data from the corresponding 
spiral leaf and an initial guess equal to the previous time frame, each constructed 
frame depends on all previous frames. It is expected that when more and more raw 
data is used, frames that are farther apart in time will contribute less. In order to 
determine this dependence, the temporal footprint was defined using the response to a 
temporal impulse function. As the variable density spiral sampling covers the central 
region of k-space more often than the outer region, the temporal footprint is expected 
to vary with the k-space radius. A numerical dynamic phantom (Figure 3.1) with 60 
frames was built. In the kx-ky plane, the phantom had only non-zero spatial frequency 
components inside a disk with radius r and an annulus with fixed width d but varying 
outer radius R. The k-space signal inside this annulus was constant and equal to one in 
all frames except for frame 13, in which it was set to two, representing an impulse 
input function in time. 
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Figure 3.1 k-space numerical phantom 
The central disk has a radius of 0.08kmax and constant signal of 1 in all 60 frames. The 
outer annulus has a constant signal of 1 in all frames except for frame 13 where the 
signal is set to 2, representing an impulse input function. The outer radius R of the 
annulus varies from 0.08kmax to kmax. 
The first frame was sampled along a fully sampled spiral trajectory (48 leaves) such 
that a high quality initial frame could be reconstructed. Each successive time frame 
was sampled using one spiral leaf with successive spiral leaves rotated using the 
golden ratio angle as before. The impulse response was calculated by Fourier 
transforming the reconstructed images and taking the average of the signal on the k-
space annulus, excluding the central k-space disk. An exponential function was fit to 
the impulse response and the temporal footprint was calculated as four times the 
exponential decay time constant corresponding to a decrease in signal of over 98%. 
This temporal footprint analysis in k-space was complemented by a similar analysis in 
image space. A 60-frame dynamic phantom consisting of a single disc at the center of 
the image with diameter varied from 0.08 × FOV to FOV was built. A temporal 
impulse function similar to the one above was applied and an exponential function was 
fit to the impulse response to get the temporal footprint. All the temporal footprint 
results were expressed in frames assuming a temporal frame rate of 0.22 s 
r=0.08kmax
d=0.08kmax
R
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(corresponding to TR = 7 ms and 32 slice encodings, parameters close to those in a 
typical patient study). 
3.5.2 Result 
Figure 3.2a shows the impulse response when the outer radius of the k-space annulus 
is 0.08kmax (10 pixels for reconstructed matrix size 256 × 256). At frame 13, the 
impulse response reaches about 60% of the impulse input magnitude and decays 
quickly to base signal in about 5 frames (1.1 s). Signal drop occurred at frame 
numbers that were approximately equal to the frame number corresponding to the 
impulse (frame 13) plus a Fibonacci number. Figure 3.2b shows the temporal footprint 
of the k-space annulus as a function of its outer radius. The temporal footprint 
increases approximately linearly with the spatial frequency radius. When the radius 
reaches kmax, the temporal footprint is 12.7 frames (2.8 s). Figure 3.2c shows the 
temporal footprint of a disk in image space as a function of its diameter. The temporal 
footprint decreases as the diameter increases due to the decreased contribution of high 
frequency components. This agrees with results in Figure 3.2b. 
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Figure 3.2 Temporal footprint analysis 
(a) Impulse response when the outer radius of the k-space annulus is 0.08kmax. The 
impulse response has an exponential decay with time constant of 1.23 frames 
corresponding to a temporal footprint of 5 frames (1.1 s). (b) Temporal footprint as a 
function of the outer radius of a k-space annulus with non-zero signal. The temporal 
footprint increases linearly with the spatial frequency up to 12.7 frames (2.7 s). (c) 
Temporal footprint as a function of the diameter of an image space disk. The temporal 
footprint decreases with the diameter. 
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3.6 Contrast Enhancement Simulation 
3.6.1 Numerical liver phantom 
A numerical dynamic phantom was constructed to simulate liver contrast enhancement 
(Figure 3.3). It contains liver, portal vein (PV), aorta, inferior vena cava (IVC) and 
pancreas with enhancement kinetics modeled from Bae et al. (25) according to a 
compartmental model of the cardiovascular system. A contrast injection rate of 2 ml/s 
and a cardiac output varying from 4 to 8 L/min were chosen for modeling. Based on 
in vivo scan parameters (reconstructed temporal resolution, tissue relaxation time and 
spiral sequence parameters as shown in Table 3.2), dynamic reference images were 
created after which noise was added.  
  
Figure 3.3 Numerical dynamic liver phantom 
Labeld are liver, aorta, portal vein, inferior vena cava and pancreas, where contrast 
enhancment curves are measured. 
3.6.2 Algorithm comparison 
LM and IRGNM were compared in the numerical liver phantom for a reconstruction 
from a fully sampled set of spiral leaves. The logarithm of the residual (defined as ||y – 
AortaIVC
Portal 
Vein
Liver
Pancreas
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E(x)||/||y||) and the update dx through the first 10 iterations are shown in Figure 3.4. 
 
Figure 3.4 Comparison of the LM and IRGNM algorithms 
(a) The logarithm of residual (defined as ||y – E(x)||/||y||) for each iteration. (b) The 
logarithm of the solution update dx for each iteration. (c) The relative root mean 
square error (RMSE) of reconstructed image at each iteration compared with the 
reference image. 
Figure 3.4a shows the LM algorithm has a faster convergence rate and lower residual 
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than IRGNM algorithm through the iterations. In Figure 3.4b, the dx decreases 
monotonically to its minimum for the LM algorithm and monotonically increases 
afterwards. This minimum corresponds to a reconstruction with the lowest relative 
root mean square error (RMSE) with respect to the reference image (Figure 3.4c). 
IRGNM shows a consistently higher relative RMSE in Figure 3.4c compared to LM. 
Therefore, in the remainder of the experiments, the LM algorithm was used combining 
with a stopping criterion that identifies the iteration with the smallest update dx. 
3.6.3 Contrast enhancement 
Tissue enhancement curves from the reference dynamic images and those from 
TRACER were compared using ROI analysis in the liver, aorta, portal vein and IVC. 
When modeling cardiac output of 7 L/min, 30 dynamic data sets were constructed, 
each with different noise having the same distribution, but otherwise identical. The 
TRACER method was performed on each of these data sets and pixel-by-pixel noise 
was calculated by taking the standard deviation of each pixel across these 30 
experiments. Signal to noise ratio of the aorta (SNRaorta = mean aorta signal/mean 
aorta noise) and portal vein (SNRPV = mean portal vein signal/mean portal vein noise) 
was calculated.  
Multi-phase sliding window (26) images were created using fully sampled (~11s) 
datasets with a 3s temporal update rate. A second sliding window reconstruction was 
performed in which a k-space mask was applied such that the effective FOV for each 
k-space region was equal to or smaller than the prescribed FOV. This effectively 
applied a temporal filter to the spiral data similar to that previously used in real-time 
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spiral imaging (19), and to the "tornado" filter (27) and KWIC method used in radial 
imaging (28). This filter limits the temporal window from which data (especially in 
the central k-space region) is used for reconstruction. Since a oversampling of two was 
used for the spiral trajectory near the center of k-space, this means that, for image 
reconstruction, the center of k-space was taken from a temporal window that is half as 
wide (~5s) compared to the edge of k-space (~11s). The SNR of these two sliding 
window reconstructions was calculated in the same manner as in TRACER. Aorta to 
portal vein contrast to noise ratio (CNR) was defined as SNRaorta – SNRPV and 
compared between TRACER and multi-phase sliding window images.  
Figure 3.5a shows the contrast enhancement curves derived from reference images 
and TRACER images in aorta, liver, portal vein and IVC in the numerical phantom. 
The reconstructed curves preserve the shape and trend of the signal and narrowly 
follow the reference curves. A delay was found in the fast changing part of the aorta 
and portal vein enhancement curves. In the liver, this delay is smaller due to its 
relatively slow signal change. This delay reaches the maximum where the signal 
change is highest and shrinks near peak enhancement. Since the steepness of the 
enhancement curves increases with increasing cardiac output, the delays of each tissue 
under different cardiac output conditions were calculated as well and shown in Figure 
3.5b. Liver parenchyma has the smallest delay of about 0.1 s. Aorta, portal vein and 
IVC have delays around 1.5 s which do not vary much with cardiac output. Figure 
3.5c shows the aorta to portal vein CNR of images reconstructed from TRACER and 
multi-phase sliding window images through time. The peak CNR from TRACER  
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Figure 3.5 Contrast enhancement comparison 
(a) Enhancement curves of aorta, portal vein, liver, IVC at 7 L/min cardiac output 
derived from TRACER images and reference images. (b) Delay of enhancement 
curves derived from TRACER compared with the reference under various simulated 
cardiac outputs. (c) Aorta to portal vein CNR of TRACER images and multi-phase 
sliding window images (with and without a tornado like filter).  
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method was 16% higher than that from multi-phase sliding window images and multi-
phase sliding window images with a tornado filter at aorta peak enhancement which 
corresponds to the optimal arterial phase. 
The tornado like filter in the sliding window reconstruction effectively reduced the 
view sharing effect, thus narrowing the CNR peak compared to the sliding window 
reconstruction. However, as less data was used for reconstruction, noise increases and 
the peak CNR remained similar to that of the unfiltered sliding window reconstruction. 
Therefore, in the remaining experiments, only the sliding window reconstruction was 
performed as a comparison. 
3.6.4 Edge sharpness 
To assess the edge sharpness during the dynamic reconstruction, the aorta diameter 
was measured for each time frame by taking the gradient of the reconstructed image, 
plotting the signal along a line across the aorta and measuring the distance between the 
two peaks representing the edges on either side of the aorta.  
 
Figure 3.6 Aorta diameter 
 
Figure 3.6 shows the aorta diameter as a function of time. When contrast arrived in 
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the aorta, the diameter had a maximal error of about 3 pixels within a period of about 
10 frames (2.2 s), coinciding with the arrival of contrast in the aorta. In the rest of the 
frames, the aorta diameter remained unchanged. 
To investigate the influence of the image quality of the initial image on the 
performance of the TRACER method, two additional TRACER reconstructions (each 
repeated 30 times as above) were performed. In these reconstructions, the standard 
deviation of the simulated noise for the initial image was increased by 50% and 100%, 
respectively, while the noise level of the remaining simulated spiral data was kept the 
same. Aorta to portal vein contrast to noise ratio was measured as above. The noise 
behavior of TRACER images with different levels of noise in the initial frame is 
shown in Figure 3.7a. With a 50% and 100% increase in noise for the initial frame, the 
noise decreased through the dynamic reconstruction in TRACER. It converged to the 
noise level of the reconstruction without the additional noise in the initial frame. The 
relative RMSE of the dynamic images showed a similar behavior (Figure 3.7b). 
 
Figure 3.7 Noise behavior of TRACER images 
(a) Noise behavior of TRACER images through time with different noise levels for the 
initial image : 0%, 50%, and 100% increase in noise standard deviation of the initial 
image compared to the rest of the simulated spiral data. Shown is the noise measured 
in the aorta. The initial higher noise level decreased with time and finally converged to 
that of the reconstruction using an initial image without the additional noise. (b) The 
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relative RMSE of reconstructed images in a) compared with the truth. The error also 
decreased as the dynamic reconstruction progresses. 
3.7 Scan Parameters 
Scan parameters for experiments performed in the following of this chapter is listed in  
Table 3.2. 
 
 
Table 3.2 Scan parameters in flow phantom, moving phantom and in vivo scans 
 
Parameter 
Moving Phantom Flow Phantom In Vivo 
3D spiral 2D EPI 
Phase 
contrast 
3D spiral 2D EPI 3D spiral 
TR/TE(ms) 6.2/0.6 6/1.5 8.6/4.2 7.2/0.6 4.2/1.2 7.2/0.6 
Flip angle 15˚ 15˚ 25˚ 15˚ 20˚ 15˚ 
Band Width 
(KHz) 
± 125 ± 62.5 ± 31.25 ± 125 ± 62.5 ± 125 
Field of view 
(mm) 
320 320 300 420 420 340 
Slice Thickness 
(mm) 
5 5 10 5 30 5 
Matrix size 
256 × 256 
× 8,16,32 
128 × 64 256 × 128 
256 × 256 × 
32 
128 × 64 
256 × 256 
× 36-50 
VENC   30cm/s    
Temporal frame 
rate (ms) 
63, 104, 
198 
147  198 147 220 
 
3.8 Moving Object Experiment 
3.8.1 Experiment design 
A set of moving phantom experiments were performed to examine the sensitivity of 
TRACER to various magnitudes of motion. In the experiments, a syringe filled with 
contrast agent was moving in and out of the field of view which contained a set of 
static phantoms. The motion of the syringe was driven by a programmable motor. The 
moving range was 38 mm at velocities of 2, 4, 6, 8, 10, 12, and 14 mm/s. The spiral 
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acquisition parameters are listed in Table 3.2. For each velocity, the acquisition was 
performed multiple times with different temporal frame rates, equal to 63 ms, 104 ms 
and 198 ms by changing the number of slice encodings. For each velocity, the 
phantom was additionally imaged using a multi-phase 2D EPI sequence (Table 3.2) to 
obtain a reference dynamic image set. For all experiments, an ROI around the syringe 
was selected and its frame-to-frame motion was computed using a cross-correlation 
registration algorithm (29). Displacement curves of the TRACER images, multi-phase 
sliding window images and 2D reference images were compared to investigate the 
reconstruction fidelity. 
3.8.2 Results 
TRACER images could faithfully record the motion of the moving phantom at various 
velocities. At the 198 ms reconstruction temporal frame rate, which is similar to the 
one obtained in the human study, the dynamic image set from low velocity 
experiments only show small spiral ringing artifacts as shown in Figure 3.8. The 
overall shape was well resolved. In contrast, the image from multi-phase sliding 
window imaging was temporal blurred and show substantial motion artifacts. 
The position curve derived from the TRACER images narrowly follows the 
reference as shown in Figure 3.9. A constant time lag of about half second is seen 
between two curves, corresponding to a position lag of less than 3mm or 2 pixels. The 
curve from multi-phase sliding window images leads the reference curve and the peak 
position is smaller than that of the reference due to temporal blurring. 
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Figure 3.8 Comparison between TRACER and Multi-phase 
One frame from dynamic image set reconstructed using TRACER at a temporal frame 
rate of 198 ms (velocity 4 mm/s) and corresponding frame from multi-phase imaging. 
At this velocity, the movement could be tracked with minor spiral ringing artifacts 
seen inside the syringe. The multi-phase image has severe motion artifact due to 
temporal blurring. 
 
Figure 3.9 Moving phantom position-time curve 
TRACER images can track the motion during the whole experiment with a constant 
lag during the movement stage. Multi-phase sliding window curve leads the reference 
and has a smaller maximum position compared with reference and TRACER. 
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For all TRACER experiments, position lag increases with moving velocity and 
reconstructed temporal frame rate as shown in Figure 3.10. This lag is less than 4mm 
for all image sets reconstructed at 63, 104 ms temporal frame rates. For the 198 ms 
temporal frame rate, a large position lag and severe artifacts were seen when velocity 
increased beyond 6 mm/s. 
 
Figure 3.10 Reconstruction lag 
Lag in position as a function of velocity and reconstructed temporal frame rate. The 
position lag increases with velocity and reconstructed temporal frame rate. 
3.9 Flow Phantom Experiment 
3.9.1 Experiment design 
A flow phantom experiment was performed to mimic liver vascular enhancement. A 
long U shaped plastic tube, through which tap water was flowing, was fixed on a 
board on top of the scanner table. A power injector was used to inject contrast agent 
into the flowing water. According to (30), maximum blood flow velocity in portal vein 
is around 15 cm/s, to which the speed of the flowing water was set. This speed was 
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confirmed using a 2D phase contrast study (Table 3.2). Contrast flow was imaged 
using a multi-phase 2D EPI sequence as well as the 3D spiral sequence (Table 3.2). 
The 2D images were used to obtain a dynamic image set from which the reference 
intensity change due to contrast flow was derived.  
3.9.2 Visual comparison 
In Figure 3.11, by comparing TRACER and reference images at the same time after 
contrast injection, it can be observed that TRACER faithfully records the bolus at this 
thick slab coverage and high spatial resolution (32 slices, slice thickness 5 mm) 
 
Figure 3.11 Reconstruction fidelity of TRACER 
Contrast bolus at 9, 11 and 13 s after injection. TRACER images could faithfully 
represent the bolus position. TRACER images achieved similar temporal frame rate as 
the reference 2D images while maintaining higher spatial resolution, coverage and 
SNR.   
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3.9.3 Enhancement curve 
TRACER and multi-phase sliding window images were reconstructed from the 3D 
dataset and the contrast flow enhancement curves were derived. These enhancement 
curves were derived from an ROI positioned inside the tube on both the 2D images 
and the 3D images at approximately the same location. For all reconstructions, the first 
(pre-contrast) frame was subtracted from all subsequent frames, allowing a clear 
visualization of the contrast bolus behavior. The result is shown in Figure 3.12. 
 
Figure 3.12 Contrast enhancement curve comparison 
TRACER enhancement curve closely follows that derived from reference image set. 
Multi-phase sliding window images at the same cross section is temporal smoothened 
and blurred, resulting in a decreased peak signal. 
The signal intensity over time at an ROI near the inlet of the tube narrowly follows 
the signal obtained in approximately the same ROI on the 2D dynamic images. Even 
in the fast signal rising region from 8 to 12 s, the signal curve difference is negligible. 
Some ringing artifacts due to highly under-sampled spirals were observed around the 
tube but do not affect the overall image quality. The temporal blurring effect is seen in 
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the multi-phase sliding window images. Contrast bolus enhancement curves are 
smoothed over time with reduced peak intensity. 
3.10 In Vivo Study 
3.10.1 Scan protocol 
This study was institutional review board approved and HIPPA-compliant. Three 
healthy volunteers (all men, aged 23 years) were imaged after obtaining informed 
consent and anonymized. Raw Fourier image data was obtained from 18 consecutive 
patients undergoing abdominal MRI with indications related to liver pathology in our 
institute (from February 23
rd
, 2011 to March 22
nd
, 2011, 6 men aged 35-62 years, 
mean age 53 years and 12 women aged 42-82 years, mean age 56 years). For human 
scans, 20 ml of Gd-DTPA (volunteers) or 10 ml Gadoxetate (patients) was injected 8-
10 s after scan initiation, which, in general, allowed for an acquisition of an initial data 
set before contrast arrival that was at most two-fold under-sampled (24 leaves) but was 
in most cases fully sampled (48 leaves). For healthy volunteers, the breath hold was as 
long as possible up to a total scan time of 80 s. For the patients, the scan time was 33 
s. For all cases, a dynamic image data set was reconstructed using one single spiral 
leaf and the previous frame as the initial guess for the TRACER reconstruction, 
resulting in a temporal frame rate of approximately 220 ms. Multi-phase sliding 
window reconstructions with a 3 s temporal update rate were performed as well. 
3.10.2 Dynamic liver images 
One patient dataset was eliminated due to severe respiration motion induced artifact. 
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All other 4D datasets were successfully reconstructed. For the 33 s breath-hold 
studies, 144 frames were created which captured the arterial phase. For the volunteer 
study with longer breath hold, the portal venous phase appeared around 50 s after 
contrast injection. From the high temporal frame rate dynamic image sets, small 
respiratory motion and stomach peristalsis were observed without motion artifacts. 
Inspecting the same anatomical location at high temporal frame rate provided an 
uninterrupted view of all liver tissue dynamic changes (see Supplementary video). An 
optimal arterial phase with only the hepatic artery enhancing was reconstructed in all 
cases. Optimal arterial and portal venous phases were retrospectively selected by 
looking at all the temporal phases of a few slices that cover both the aorta and hepatic 
artery (Figure 3.13a). 
Temporally distinct tissue enhancements were observed for the aorta, hepatic 
artery, kidney, spleen, portal vein, inferior vena cava, and liver parenchyma. In the 
spleen, the typical spatially varying enhancement pattern was well visualized. In a 
patient with hepatocellular carcinoma, gradual arterial enhancement of the tumor was 
observed (Figure 3.13b).The arterial enhancement of the tumor could be confidently 
identified with the high temporal resolution of TRACER and the consequent detailed 
depiction of the enhancement evolution. In one study, the patient failed to follow the 
breath-hold instruction during the scan and continued shallow free breathing. Despite 
ringing artifacts, TRACER was still able to produce diagnostic images (Figure 3.13c). 
 47 
 
Figure 3.13 Retrospectively selected optimal arterial phases and sub-phases 
Each image is labeled with its frame number and acquisition time after scan initiation. 
(a) A healthy volunteer study showing start of arterial enhancement, optimal arterial 
phase, and two late sub-phases. (b) A hepatocellular carcinoma case showing the 
arterial enhancement of the tumor (arrows indicated). Retrospectively selected sub 
arterial phases depicted the gradual tumor enhancement evolution. (c) A liver donor 
patient who failed to follow instructions and performed shallow breathing instead. 
Four phases from an early arterial phase to early portal venous phase are shown to 
illustrate the possibility to retrospectively select optimal sub-phases. Due to diaphragm 
motion, the liver position changed noticeably during the scan (arrows indicated). 
 
3.10.3 Quantitative analysis 
To assess the quality of the optimal arterial phase, hepatic artery to portal vein CNR 
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was compared between TRACER images and multi-phase sliding window images. To 
get accurate signal measurement within a larger ROI, the aorta was used as a substitute 
of the hepatic artery. One slice containing the main portal vein was selected for 
measurement. The CNR was derived as mean signal intensity difference between aorta 
and portal vein divided by the standard deviation of an ROI containing homogeneous 
liver tissue near both the aorta and the portal vein, which was done to approximate the 
local noise characteristics in this parallel imaging study. The Student’s t-test was used 
to compare peak CNR obtained with TRACER and with the multi-phase sliding 
window method. 
TRACER reconstructions had significantly higher aorta to portal vein CNR 
compared to multi-phase sliding window images (P < 0.001). Peak aorta to portal vein 
CNR was 31 ± 27% higher for the TRACER reconstruction compared to that of the 
sliding window reconstruction, corresponding to a range between 9% and 133%. In 14 
cases, the CNR increase was over 20%. 
The peak aorta to portal vein CNR occurred during the arterial phase before the 
portal vein enhanced. It could be missed in multi-phases sliding window images when 
the hepatic artery is not fully enhanced or the portal vein has already enhanced as 
shown in Figure 3.14. Instead, the TRACER technique gives higher aorta to portal 
vein CNR and a better visual differentiation between hepatic artery and portal vein. 
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Figure 3.14 TRACER shows improved aorta-to portal vein CNR 
(a) CNR of TRACER and multi-phase sliding window images. (Solid markers 
represent multi-phase and hollow markers represent additional phases by sliding 
window reconstruction). The TRACER image set has a 44% aorta to portal vein peak 
CNR increase compared to the multi-phase images. (b) Arrows indicate a region 
where both hepatic artery and portal vein could be seen. The peak aorta to portal vein 
CNR was at a time (labeled as 3) when aorta was around its highest signal and portal 
vein has not enhanced. In multi-phase images, the two arterial phases had lower aorta 
to portal vein CNR. In one phase (labeled as 1), the hepatic artery was not fully 
enhanced and appears dim. In the other phase (labeled as 2), the portal vein has 
enhanced thus contaminating the arterial phase. 
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In one study, the scan initiation was delayed by around 5 seconds due to an 
unexpectedly long breath hold instruction. The pure arterial phase was missed using 
the multi-phase sliding window reconstruction but TRACER reconstruction still 
provided a high quality arterial phase as shown in Figure 3.15. 
 
Figure 3.15 Recovering missing arterial phase from TRACER 
Missing arterial phase in multi-phase images could be retrospectively selected in 
TRACER images for a delayed scan initiation study. (a) Maximum aorta to portal vein 
CNR of multi-phase images is only half of the CNR in TRACER images. (b) Due to 
signal average effect, portal vein enhancement is seen in all multi-phase images. Even 
the phase with maximum aorta to portal vein CNR was contaminated by portal vein 
enhancement (arrow), whereas TRACER was still able to give a high quality arterial 
phase, with the portal vein (arrow) not yet enhanced. 
3.11 Discussion 
Our preliminary data tends to confirm that the nonlinear Temporal Resolution 
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temporal footprint of time resolved imaging. Our study specifically demonstrates the 
feasibility of using a 3D golden ratio spiral acquisition with TRACER reconstruction 
to achieve high temporal frame rates for whole liver imaging at a spatial resolution 
normally requiring around 11 seconds of data sampling. This ensures that optimal 
arterial sub-phases can be selected retrospectively, thereby eliminating bolus timing 
errors and may ultimately allow studying contrast enhancement kinetics at a new level 
of temporal-spatial details. The temporal fidelity and dynamic tracking capability were 
validated by numerical, flow and motion phantom experiments. Increased peak aorta 
to portal vein CNR compared to a sliding window reconstruction was demonstrated in 
vivo. 
Hepatic arterial and portal venous sources of blood to the liver are briefly 
separated in time which allows distinguishing arterial enhancing tumors from normal 
liver which is primarily supplied by portal vein. Detection and diagnosis of malignant 
liver lesions require obtaining both arterial and portal phase images. In clinical 
practice, there is a sizable chance that the arterial phase is missed due to imperfect 
bolus timing. Additionally, each phase spans a long acquisition window, potentially 
resulting in a corrupted arterial phase with some portal venous enhancement. With 
high temporal frame rate, TRACER can provide the optimal arterial phases. 
Retrospectively selecting the optimal phases relieves the need for accurate bolus 
timing. An average 30% peak aorta to portal vein CNR increase indicates a better 
differentiation between arterial and portal enhancement. In addition, the high temporal 
frame rate allows interrogating sub-arterial phases and characterization of 
enhancement kinetics. Multiple breath holds are still needed with this technique to 
 52 
acquire the later venous and delayed phases. 
In TRACER, each frame is reconstructed using a single spiral leaf for each slice 
encoding, resulting in a high 3D temporal update. This can intrinsically capture small 
motions as was demonstrated in moving object and flow phantom experiments. When 
breathing is shallow, TRACER can, to a certain extent, still produce diagnostic images 
as shown in Figure 3.13c. Also detailed gastric and intestinal peristalsis was observed 
in many cases. This dynamic organ movement and deformation information has not 
been shown previously with 3D acquisitions. 
Numerous methods have been proposed to accelerate DCE-MRI. Among recent 
approaches, k-t PCA (31,32) and partially separable function (PSF) (33) utilize the 
spatial-temporal correlation by incorporating basis functions from calibration data. 
PICCS (34), sparse-CAPR (35), HYPRIT(36,37), and RICS (38) are techniques based 
on compressed sensing (CS), where the temporal update compared to a reference or 
composite image is constrained (sparse) in an appropriately chosen domain. Other 
methods include the GraDes (39) method, which iteratively updates a sparse solution 
to achieve a high acceleration factor, and Nonlocal Means reconstruction (40), which 
constrains the spatial and temporal neighborhood similarities based on signal 
similarities. 
Similar to these approaches, TRACER utilizes the temporal redundancy in DCE-
MRI as a temporal constraint. The constraint between the solutions at consecutive time 
frames is implicit. This is due to the stopping criterion used, which stops the iterative 
solver when the norm of the update no longer decreases. In practice, for the heavily 
under-sampled spiral data used here, this criterion leads to very small number of 
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iterations, typically between 1 and 3. In our experience, this limits the amount of noise 
amplification and under-sampling artifact present in the final solution. Additionally, it 
leads to an implicit constraint on the amount of change permitted between successive 
time frames, and not just between intermediate solutions of the iterative LM solver. 
Adding an additional spatial or temporal constraint (such as an L1 norm in a certain 
transformed domain) in Eq [3.4] may be useful and could further improve the 
reconstruction accuracy at the potential expense of increased computation time. 
Compared to other approaches utilizing a reference or composite image, TRACER 
inherently updates this reference image together with the reconstruction. Additionally, 
and in contrast to some of the other methods, a given frame will only contain 
information from data sampled on or before that time point. This introduces a certain 
lag when the contrast change is very fast, as was shown in the contrast enhancement 
and impulse response simulations. 
Dynamic imaging methods with view sharing commonly have a temporal footprint 
as long as the duration of a fully sampled data set like in sliding window. This 
footprint is reduced by the acceleration factor when parallel imaging is used. Here the 
impulse response function is used to calculate the temporal footprint. Although an 
impulse response analysis is only valid for a linear reconstruction, its results were 
found to be in good agreement with the numerical liver contrast enhancement 
phantom. It is speculated that the slowly changing coil sensitivities observed in both 
the phantom and in vivo reconstructions may make the input response analysis still a 
useful tool. Our results demonstrate TRACER has a variable temporal footprint 
depending on the k-space frequency. This temporal footprint is about 5 frames or 
 54 
~1.1s (1/10 duration of the fully sampled dataset) or fewer for low spatial frequencies. 
For high spatial frequencies, the temporal footprint is around 12 frames or 2.7s. In 
comparison, multi-phase imaging has a constant temporal footprint of 48 frames or 
~11s in a typical patient scan. As the k-space energy is mostly concentrated in low 
frequencies, it is expected that TRACER results are minimally affected by temporal 
blurring, as shown in the moving phantom position curve and flow phantom 
enhancement curve. This may also explain the enhancement delay seen in the 
numerical dynamic liver phantom experiment. Organs like aorta and portal vein have 
broader spatial frequency support. The corresponding increased temporal footprint 
combined with the fast temporal changes in these vessels, can therefore be expected to 
induce a delay between the reconstructed signal curve and the true signal curve that is 
larger than that of the liver. Indeed, the maximum aorta delay in the numerical liver 
phantom was two seconds corresponding to a duration of nine frames which is in the 
range of temporal footprints found using the impulse response analysis.  
The reduced temporal footprint may also explain why the TRACER reconstruction 
produced higher aorta to portal vein CNR when compared to multi-phase technique 
and sliding window reconstruction which incorporate certain k-space information 
across a long acquisition window and are affected by temporal blurring due to the 
repeated sampling of the center of k-space in spiral sampling. The latter remained true 
to a lesser extent when a tornado like filter was used in the sliding window 
reconstruction. Accurate enhancement evolution would provide a way to differentiate 
benign and malignant tumors as well as new insights into contrast uptake 
pharmacokinetics in lesions. The patient case with arterially enhancing hepatocellular 
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carcinoma provides a vivid illustration of using high temporal frame rate images to 
probe arterial enhancement kinetics. 
Spiral sampling has the advantage of sampling more k-space locations in one TR, 
making it well-suited for the TRACER method. On the other hand, it suffers from off-
resonance and eddy current artifacts. However, for the typical axial orientation used in 
liver imaging combined with effective fat suppression and careful shimming, it was 
found that TRACER is only mildly affected by these artifacts. The highly under-
sampled spiral trajectory caused inhomogeneous intensity changes from frame to 
frame. A temporal median filter greatly reduces this artifact while other filters like the 
mean filter or the more elaborate Kalman filter (41) are also possible. Additionally, 
information from a single spiral leaf may not be adequate when the dynamic change 
between two frames is large. This may result in inaccurate reconstruction and spiral 
under-sampling (ringing) artifacts. In the moving phantom experiments, when the 
temporal frame rate is high and the moving velocity is low, the shape and edge of the 
object can be well preserved. This observation in the phantom is consistent with the 
observation of adequate image quality in the TRACER reconstruction in the presence 
of shallow breathing. However, TRACER is currently not able to handle arbitrary 
respiratory motion, leading to blurring and ghosting artifacts.  
A drawback of the proposed reconstruction method is the computational cost. This 
is in part due to the high number of reconstructed frames and the iterative nature of the 
solver. An oversampling factor of 3 was chosen to reduce errors when using in a 
convolution to approximate the gridding and regridding operations needed by the 
iterative solver (42). Compared to a more conventional oversampling factor of 2, this 
 56 
increased computation time by ~8% while decreasing the peak RMSE by ~0.4% in the 
numerical simulation. The computation times for the whole 3D volume were ~2 hours 
using MATLAB (2009a, The MathWorks, Natick, MA) for a matrix of 256 × 256 × 40 
and 192 frames on a Dell PowerEdge R910 server (32 cores, 64GB memory). For a 
single slice, peak memory usage during initialization was 15MB and increased to 
240MB during the subsequent nonlinear solver. Since the slice direction is fully 
encoded, an FFT can be performed at the beginning, such that each slice can be 
reconstructed independently. This means that the time-resolved reconstruction of 
several slices can be performed simultaneously on a modern multi-core desktop 
computer. The computation time could be potentially reduced with optimized C/C++ 
code and/or by using a GPU implementation (43). Furthermore, a linearized 
formulation of the encoding function with periodically updated coil sensitivities may 
help further decrease overall computation time, but its effect on reconstruction 
accuracy remains to be investigated. 
3.12 Conclusion 
 
By enforcing image fidelity to the sampled data of a time frame and imposing 
consistency with the previous image frame, Temporal Resolution Acceleration with 
Constrained Evolution Reconstruction (TRACER) reduces the temporal footprint of 
dynamic 3D contrast enhanced MRI of the liver while maintaining image quality. 
TRACER eliminates the need for bolus timing and allows the retrospective selection 
of optimal arterial phases. High temporal frame rate data sets allow the visualization 
of the continuous enhancement process.
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CHAPTER 4  
CEREBRAL PERFUSION MAPPING 
Quantitative susceptibility mapping (QSM) has the potential to quantify contrast agent 
bio-distribution. The purpose of this study is to develop a QSM technique with 
sufficient temporal resolution for mapping first pass contrast agent concentration in 
brain perfusion quantification. Four-echo T2* weighed 3D spoiled gradient echo phase 
images were acquired with a golden angle ordered spiral sequence during bolus 
injection of 0.1mmol/kg gadobutrol at 2ml/s. Time resolved field inhomogeneity maps 
were reconstructed using constrained reconstruction, TRACER. Contrast agent 
induced field map for each time point was deconvolved with a dipole inversion solver, 
MEDI, for concentration mapping. Cerebral blood volume and cerebral blood flow 
was computed from the arterial and tissue concentration curves. Initial in-vivo brain 
imaging data demonstrated the feasibility of mapping time resolved contrast agent 
quantification using the proposed method. Cerebral blood flow agrees with that 
obtained from arterial spin labeling technique. Dynamic quantitative susceptibility 
maps allowed brain perfusion mapping with cerebral blood flow value in good 
agreement with arterial spin labeling. 
4.1 Introduction 
Dynamic Susceptibility Contrast (DSC) MRI employs the magnetic field 
inhomogeneity change caused by paramagnetic contrast agent to assess cerebral 
perfusion (44-47). Time resolved contrast agent susceptibility effects during the first 
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passage are used to quantify arterial input function (AIF) and tissue contrast curves, 
which are then used to compute cerebral blood flow (CBF) and cerebral blood volume 
(CBV) according to indicator dilution theory.  
Commonly the contrast concentration time curves are obtained by measuring ΔR2* 
of artery and tissue using a fast sequence like single shot EPI and then converting to 
contrast agent concentration  according to the T2 relaxivity of the contrast agent. 
Conversion from ΔR2* to concentration assumes a linear relationship and that the 
contrast agent T1 effects are negligible. However, ΔR2* and contrast concentration 
actually have a quadratic relationship and the AIF obtained assuming a linear 
relationship may suffer substantial error (48-50). The coefficients of the quadratic 
function need to be calibrated for a specific contrast agent (like Gd-DTPA) and are 
hematocrit dependent (48). The tissue concentration is affected by the estimate of 
tissue relaxivity, which may also influence the perfusion map accuracy (50-52). For 
the unchanged T1 assumption, usually a large TR is used, but it could still be a source 
of error (49). In tumor patients with leaky capillaries, the tumor will have substantial 
signal enhancement, which needs a sophisticated correction scheme for accurate 
perfusion quantification (53,54).  
On the other hand, MRI phase data also provides important information regarding 
cerebral hemodynamics, especially when contrast agent produces a big local 
susceptibility change. The early work in cerebral perfusion (55) has attempted to use 
phase change to assess the relative contrast concentration and CBV. Recent studies 
investigated measuring AIF (56) with MR phase data as well. In certain vessel 
geometry condition, phase shifts is linear with contrast concentration and the derived 
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AIF from phase shows a substantial SNR improvement over that from ΔR2* method 
(57). Measuring Gd concentration from MRI phase data may be a simpler and more 
accurate approach to quantifying tissue perfusion. De Rochefort et al. (58) quantitated 
first pass aorta Gd concentration under piecewise constant assumption. Recently 
developed quantitative susceptibility mapping (QSM) (59) enables susceptibility 
measurement of more complicated anatomic structures and Gd contrast bio-
distribution. Voxel wise susceptibility mapping with sufficient temporal resolution is 
potentially useful for cerebral perfusion mapping. Bonekamp et. al showed perfusion 
mapping results from susceptibility obtained from 2D EPI phase data (60). In this 
work, we proposed to use 3D multi-echo spiral sequence and constrained 
reconstruction to achieve sufficient spatial and temporal resolution needed for 
susceptibility mapping. Dynamic Gd concentration maps were reconstructed from the 
multi-echo phase images. CBF and CBV maps are obtained thereafter. In vivo study 
demonstrates the feasibility of the proposed method. 
4.2 Data Acquisition 
 
A spoiled 3D 4-echo stack-of-spiral sequence was developed for data acquisition 
(Figure 4.1). The spiral trajectory in kx-ky plane has a variable density such that the k-
space center is three-fold oversampled whereas the edge is under-sampled by a factor 
of 0.8. Consecutive spirals are interleaved by the golden ratio angle of 220˚. For each 
angle, a full set of slice encodings is acquired (partially encoded) before moving to the 
next angle.  
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Figure 4.1 Multi-echo spiral pulse sequence 
3D multi-echo stack of spirals gradient echo sequence. Bipolar flow compensation 
gradient (shaded in gray) is added in all directions to null the first order gradient 
moment. 
After each spiral readout, the spiral is refocused to the k-space center and flow 
compensated before next echo. Flow compensation utilizes bipolar first moment 
nulling gradient added before each echo except for the first one. The width and 
amplitude of the flow compensation gradients are computed using the following 
constraints: 
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The gradient moment nulling markedly reduces spiral ringing displacement artifacts of 
arteries and veins as shown in Figure 4.2. 
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Figure 4.2 Effect of flow compensation gradient 
Images reconstructed with and without flow compensation. Flow compensation 
markedly reduced the spiral artifact from artery and veins. 
4.3 Dynamic Field Map Reconstruction 
The golden angle view ordered spiral acquisition was reconstructed using Temporal 
Resolution Acceleration with Constrained Reconstruction (TRACER) (61). A 3D 
image of the first echo is reconstructed with a set of fully sampled spirals acquired at 
the beginning of the scan. Coil sensitivity maps were computed from the first echo and 
were used to compute the initial reference images of later echoes using conjugate 
gradient SENSE reconstruction. For TRACER reconstruction of dynamic image 
frames, instead of jointly solving both image content and coil sensitivity map, only 
image content was solved using the fixed coil sensitivity maps. In the previous study, 
each frame was updated by one spiral and was constrained by taking the previous 
frame as the initial guess for the solver. Here we improved TRACER by taking m 
consecutive spirals, from index N-m+1 to index N, when computing frame N. As more 
k-space is covered when solving one frame, the under-sampling artifacts are greatly 
No flow
compensation 
With flow
compensation 
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reduced compared with a single spiral update while the update information from 
acquired data is still from spiral N. On the other hand, m should be small to eliminate 
temporal blurring. As consecutively acquired spirals were interleaved with golden 
angle view order, m = 3, 5, 8, 13, 21 will give a uniform coverage of the k-space while 
minimizing under-sampling artifacts.  
After reconstruction of multi-echo complex 4D images, the phase images of the 
first frame (pre Gd administration) was subtracted from all later frames. Then for each 
frame, this difference phase data was linearly fitted through all echoes to produce the 
magnetic field map corresponding to the evolving Gd contrast agent biodistribution. 
4.4 Perfusion Mapping 
The susceptibility map of contrast agent for each frame was computed from the field 
map using morphology enabled dipole inversion (MEDI) solver. The contrast 
concentration maps were then computed from the susceptibility map, using the molar 
susceptibility of Gd
3+
 (326ppm L/mol) (62) . A susceptibility offset was applied to 
each frame by setting susceptibility in ventricles to zero. An arterial input function 
chosen from the middle cerebral artery was used for voxel-by-voxel de-convolution of 
the tissue contrast curve. The tissue concentration curve C(t) is the convolution of AIF 
and residual function R(t) scaled by the CBF: 
 
  ( )  
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        ( )    ( ) [4.1] 
The correction factor    (         ) (            ), where              
 63 
and                 accounts for the hematocrit difference between large vessels 
and capillaries. The density of brain tissue is set to 1.04 g/mL (46). The residual 
function R(t) is computed using truncated SVD de-convolution (63) where the 
truncation threshold is taken to be 0.2 and CBF is taken to be the maximum value of 
R(t). Cerebral blood volume was determined by integrating the area under the 
concentration time curve and normalized to the area of arterial input function: 
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∫    ( )
    
 
  
 [4.2] 
In the implementation, we choose the time range from the start of the enhancement to 
when the signal drops to noise level. 
4.5 Flow Phantom Study 
4.5.1 Experiment setup 
 
A flow phantom experiment was carried out to validate the measured contrast 
concentration using dynamic susceptibility mapping. A U-shaped vinyl tube was 
connected to a pump and fixed inside a plastic box filled with water. A three-way 
valve on the inlet was connected to the power injector to allow contrast injection. The 
pump circulates water from a reservoir with contrast concentration of 0.5 mM through 
the tube at a flow rate of 5.5 ml/s. The plastic box in the imaging FOV contains water 
with 1mM contrast agent to enhance background signal. Gadovist diluted to 100mM 
was filled in the power injector. For the dynamic scan described below, 3mL of the 
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solution followed by 10mL saline flush was injected at 1mL/s. The phantom in the 
FOV is shown in Figure 4.3 
 
Figure 4.3 Flow phantom setup 
A magnitude image showing the flow phantom setup. ROI A on the inlet and B on the 
outlet were used to plot concentration time curves. 
4.5.2 Scan protocol 
The proposed multi-echo spiral sequence was used to imaging the contrast dynamics. 
A coronal slab was prescribed to cover the whole tube. Scan parameters for the scan 
were: dual-echo TE1/TE2/TR = 1.0/7.75/15.6 ms, FA=30 ˚, FOV=24cm, slice 
thickness = 3mm, matrix size = 160×160×14, BW = ±125kHz. The contrast injection 
started 5 seconds after the scan initiation. Total scan time was 48 seconds. In addition, 
a 2D spiral sequence was used as a reference scan of the contrast dynamics. One 
coronal slice was prescribed to covers the whole tube in the imaging FOV. Scan 
parameters were: TE/TR = 1.7/10 ms, FA = 40˚, FOV = 24cm, slice thickness = 
12mm, matrix size = 160×160, BW = ±125kHz. Scan time for one slice took 242ms. 
4.5.3 Concentration time curve 
Two ROIs were drawn from the straight part of the tube that was parallel to B0 field. 
A
B
B0
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The reference contrast concentration within the ROI was obtained from the phase data 
of 2D scan according to equation: 
 
 ( )   ( )  
 
 
            [4.3] 
Dynamic susceptibility maps were computed from the data acquired using multi-echo 
spiral sequence and reconstructed with TRACER. Then the concentration time curves 
were compared with that from 2D reference scan.  
 
Figure 4.4 Concentration time curves 
Contrast concentration time curves computed from dynamic susceptibility mapping 
agree well with that obtained from phase of the referencd 2D scan. 
Figure 4.4 shows the corresponding time curves starting from contrast injection. 
The concentration measured from dynamic susceptibility mapping agrees well with 
that obtained from the 2D reference scan at both ROIs. A dispersion and reduced 
amplitude of the enhancement curves was found on the outlet (B) compared with inlet 
(A). The integral of the concentration time curves from dynamic susceptibility 
mapping is 57.8      and 53.9      in ROI A and B, which corresponds to 
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total injection amount 318 mmol and 296mmol (flow rate 5.5 ml/s). This is in 
accordance with the 300mM total injection amount with the discrepancy due to 
injection variance and reconstruction noise. 
4.6 In Vivo Study 
4.6.1 Scan protocol 
This study was institutional review board approved and HIPPA-compliant. Three 
healthy volunteers (2 male, 1 female), brain imaging was performed using an 8-
channel head coil on a 3T scanner (Signal HDxt; GE Medical Systems) after obtaining 
informed consent. For spiral axial DSC scan, typical scan parameters were: 4 echoes, 
TR/TEfirst/TElast = 34.3/0.7/25.3 ms, bandwidth = ± 125 kHz, flip angle = 15˚, FOV = 
22cm, matrix size = 200×200×22, voxel size = 1.1×1.1×3 mm
3
. The scan slab was 
prescribed to cover most of the cerebrum including the middle cerebral artery for AIF 
measurement. Total scan time was about two and a half minutes. Twenty seconds after 
scan initiation, 0.1mmol/kg gadobutrol (Gd-BT-DO3A, Gadovist) was injected at 
3ml/s followed by 30ml saline flush at 3ml/s. The injection delay is necessary for 
reconstructing a pre-contrast reference image.  
4.6.2 Perfusion imaging 
Dynamic contrast concentration maps were reconstructed at a temporal frame rate of 
0.7 seconds. A Gaussian smoothing with kernel width of three pixels is applied on the 
perfusion maps. Figure 4.5 shows the time resolved phase curves of one voxel in gray 
matter. The phase change follows the contrast agent arrival and is proportional to the 
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echo time. With linearly spaced echo time, the phase different between each echo is 
also linearly spaced. At peak enhancement, substantial phase change in the gray matter 
could be observed. 
 
Figure 4.5 Time resolved phase curves 
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 Figure 4.6a shows the measured AIF in middle cerebral artery. The peak bolus 
concentration reaches to 6mM. Shown in Figure 4.6b are the contrast concentration 
maps at five time points that are marked on the AIF curve. They correspond to pre-
contrast, early arterial phase, peak arterial phase, late arterial phase, and equilibrium 
phase. The contrast arrival and wash out stages in brain vessels and tissues could be 
observed. 
 
Figure 4.6 Contrast concentration time curves 
(a) AIF measured from middle cerebral artery that used for perfusion map 
quantification. (b) Measured contrast agent concentration (log plot) at five time points 
during the contrast passage. Then enhancement pattern in different regions could be 
observed. 
Figure 4.7 shows the measured CBF and CBV maps in five slices that are in the 
center of the brain. Grey white matter contrast could be observed. The mean CBF 
value is around 65ml/100g/min for gray matter and 25ml/100g/min for white matter. 
The mean CBV value is around 5.6mL/100g for gray matter and 2.3 mL/100g for 
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white matter. These values are within the physiological ranges from previous studies 
(46). Some under-estimation of the perfusion value is found in the boundary of frontal 
lobe. This is due to the spiral artifact from high inhomogeneity field in the frontal lobe 
and error from susceptibility mapping. 
 
Figure 4.7 CBF and CBV maps 
CBF and CBV maps of five slices in the middle of the brain. 
4.6.3 Comparison with ASL 
 
An ASL scan was performed before contrast injection followed by a dynamic DSC 
scan. A commercial pulsed continuous axial ASL was performed. The sequence 
employs multi-arm spiral imaging with eight arms, each with 512 readout points 
(bandwidth = ± 62.5 kHz), giving an in plane resolution of 3.2mm. Other scan 
parameters were: TR/TE = 4.9s/11ms, FOV = 22cm, slice thickness = 2mm, number 
of slices = 60. Total scan time was 5 minutes. Post processing was performed on the 
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scanner console to obtain the CBF map. 
The magnitude image from the first echo of DSC scan was co-registered with the 
proton density images acquired in ASL with FSL toolbox (64). The transformation 
matrix is used to register ASL CBF map. ROIs in gray and white matter were 
identified in the ASL CBF maps. Within each ROI, mean and standard deviation of 
CBF value from both ASL and dynamic QSM were measured and compared.  
 
Figure 4.8 Comparison of CBF from ASL and dynamic QSM 
The value from dynamic QSM is close to that from ASL. The CBF obtained from 
QSM in general has larger standard deviation. The QSM derived CBF value has large 
error in the boundary due to background removal procedures in QSM. 
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Figure 4.8 shows the comparison of CBF maps obtained from ASL and dynamic 
QSM. Eight ROIs, 4 in gray matter and 4 in white matter are labeled. Mean and 
standard deviation of CBF in gray and white matter are plotted in Figure 4.8b. In 
general, the mean CBF values from dynamic QSM agree with CBF from ASL in each 
ROI, while the standard deviation in QSM CBF is higher. 
4.7 Discussion 
 
Quantitative susceptibility mapping (QSM) is an emerging technique that provides 
pathophysiology information complementary to traditional T1, T2 and T2* weighed 
imaging (65-70). QSM has been successful in static tissue imaging (59,71), with a 
scan time usually in minutes. In this study, for the first time, we demonstrate dynamic 
quantitative susceptibility mapping by using spiral acquisition and constrained 
reconstruction. The reconstructed dynamic susceptibility maps, with sub-second 
temporal frame rate and relative high spatial resolution, is used for quantitative 
cerebral perfusion imaging. 
Imaging first pass contrast agent administration requires high temporal resolution. 
Different acquisition and reconstruction techniques have been proposed for first pass 
perfusion MRI and DSC MRI (31,61,72-74). In DSC MRI, ΔR2* from magnitude 
image is used for contrast agent quantification. Directly quantifying susceptibility 
would open a new path for DSC MRI. However, this is hampered by the lengthy scan 
time of susceptibility mapping. Non-Cartesian sampling has been proposed to 
accelerate QSM (75). To achieve the desired temporal resolution for capturing contrast 
dynamics, we extended the TRACER technique to multi-echo acquisition in 
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susceptibility mapping. As Figure 4.2 demonstrates, flow compensation is necessary to 
eliminate flow induced displacement artifact. This is especially important for DSC 
MRI, where the arteries are used to obtain AIF. In order to mitigate decreased 
temporal resolution in multi-echo scan, a sliding-window TRACER is employed here. 
This scheme can greatly reduce the spiral under-sampling artifacts when there is 
substantial temporal change between adjacent spirals. With a small sliding window, 
the temporal tracking ability of TRACER is only slightly affected. The reduced noise 
in the enhancement curve is crucial for AIF de-convolution and improves the SNR of 
final perfusion maps.   
The dipole inversion solver for susceptibility mapping is also adapted to dynamic 
imaging. For gadolinium quantification, only contrast agent induced magnetic field is 
of the interest. Subtraction of baseline field map can eliminate most of the unwanted 
field contribution from background susceptibility sources. This subtraction also 
alleviates the phase unwrapping problem when high susceptibility source like 
gadolinium contrast agent is present. Background field removal is performed on this 
difference field to get rid of any residual field from susceptibility sources outside the 
imaging FOV or from B0 field variation. 
The major advantage of the proposed method is its direct measurement of contrast 
agent concentration from susceptibility. R2* based contrast quantification is subject to 
error induced from the nonlinear relationship between ΔR2* and AIF. Linear model 
can either overestimate or underestimate the CBF value. Nonlinear is more preferable 
but subject to choice of the parameters (50). Tissue relaxivity is also known to vary 
according to the contrast agent bio-distribution (76) and the value measured from 
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different method has a big discrepancy. Furthermore, T1 effect is not negligible when 
the blood brain barrier is intact. These conditions all contribute to the uncertainty of 
the estimated concentration.  
Susceptibility is proportional to contrast concentration with a scaling factor of 
Gd
3+
 molar susceptibility. The computed concentration does not rely on assumptions 
of vessel geometry or physiological parameter (like Hematocrit). The ideal of AIF 
measurement from phase in a straight artery is extended to all tissue with the help of 
magnetic dipole inversion. In the flow phantom experiment, the concentration 
obtained from susceptibility agrees well with that from phase as shown in Figure 4.4. 
This experiment also demonstrates the temporal tracking ability of TRACER 
reconstruction. The concentration curves closely follow the concentration curves from 
2D scan that has a temporal resolution of 242ms. 
Our initial in vivo results demonstrate the feasibility of using susceptibility for Gd 
quantification in perfusion mapping. The CBF and CBF maps show good gray and 
white matter contrast. The perfusion values fall in the physiological range. The CBF 
measurement generally agrees with the ASL measurement. Some discrepancy is seen 
too. In dynamic QSM method, the straight sinus and superior sagittal sinus shows 
large CBF value. In comparison, ASL does not capture the vein CBF due to its tagging 
mechanism. Another discrepancy is primarily in the frontal lobe and the posterior gray 
matter region. Dynamic QSM method underestimates CBF values in these regions. 
This is primarily due to imperfect background removal in QSM, which tends to result 
in errors in the boundaries of the image. This needs further investigation to improve. 
A few areas could be further explored to improve the technique. Multi-slice 2D 
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acquisition with large TR is promised to provide improved SNR compared to the 
current 3D acquisition. How 2D acquisition could be integrated with TRACER 
reconstruction and affect dipole inversion needs to be evaluated. Currently, data 
processing takes tens of minutes on a multi-core server. To make the technique clinic 
applicable, magnitude of acceleration is possible by optimizing and paralleling the 
solver. 
4.8 Conclusion 
Contrast agent concentration time curves are quantitated using multi-echo spiral 
acquisition, constrained image reconstruction, and quantitative susceptibility mapping. 
The concentration maps are used to extract arterial input function and tissue 
concentration curves for quantitative cerebral perfusion. Phantom validation and in 
vivo comparison demonstrate the feasibility of perfusion mapping using dynamic 
QSM.
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CHAPTER 5  
VENOUS OXYGENATION QUANTIFICATION 
Venous blood oxygen saturation is an indicator of brain oxygen consumption and can 
be measured directly from quantitative susceptibility mapping (QSM) by 
deconvolving the MR phase signal. However, accurate estimation of the susceptibility 
of blood may be affected by flow induced phase in the presence of imaging gradient 
and the inhomogeneous susceptibility field gradient. Flow compensation is proposed 
for QSM by using a fully flow compensated multi-echo GRE sequence for data 
acquisition and a quadratic fit for the flow phase associated with inhomogeneity field 
gradient. This flow compensated QSM is validated in phantom experiments. 
Preliminary results from in vivo human imaging demonstrate improvements in the 
quantitative susceptibility map and in the estimated venous oxygen saturation values. 
5.1 Introduction 
Magnetic susceptibility is a physical tissue property that varies in healthy tissue and 
may also change with pathologic conditions. Susceptibility provides information 
complementary to traditional T1, T2 and T2
*
 weighted images. Quantitative 
Susceptibility Mapping (QSM) computes the magnetic susceptibility distribution 
based on the magnetic field inhomogeneity generated by magnetic sources (68,77-83). 
QSM has been shown to provide useful anatomical and clinical information for brain 
iron quantification (66,84), subthalamic nucleus visualization (85) , and cerebral 
microbleeds characterization (67). Since magnetic susceptibility is linear in the 
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deoxyhemoglobin concentration, it also allows venous oxygen saturation 
quantification (65,86-88). However, blood flow induced artifacts hamper accurate 
measurement of blood susceptibility. QSM employs a dipole deconvolution of the 
magnetic field measured by MRI to obtain the susceptibility distribution. Typically, to 
compute the field map, multi-echo gradient echo phase images are acquired and the 
field map is estimated by performing a linear fit of the phase to the echo time (TE). 
However, in the presence of flow, usually between 10~20 cm/s in the veins (89,90) 
and local spatial field inhomogeneity, this linear assumption does not hold. Travelling 
spins accumulate additional phase that may cause vessel misalignment and erroneous 
magnetic field estimation. Without correction, the computed field map in vessels may 
not be accurate and may lead to unreliable blood susceptibility and oxygen saturation 
values.  
In this chapter, the theoretic relationship between the phase, both in image space 
and k-space, of flowing spins and TE is derived. A data acquisition and a 
reconstruction approach is proposed to improve the vessel susceptibility 
quantification. In the data acquisition, gradient moment nulling is added to the 
readout, phase and slice encoding directions for all echoes. In the data reconstruction, 
a quadratic fit is used for regions exhibiting flow while a linear fit is used for regions 
with static spins. Phantom experiments are performed to validate the theory and 
demonstrate the improved field map estimation. Improved image quality is 
demonstrated in human brain images. More consistent venous oxygen saturation 
measurement is achieved with the improved susceptibility value. 
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5.2 Theory 
5.2.1 Signal modeling 
The k-space MRI signal s at time   acquired for a static spin isochromat could be 
written as: 
 
 ( )  ∫ ( )   (     ( )   ∫  ( )
 
     )    [5.1] 
where  ( ) is the density of the spin isochromats at position r,   is an initial phase 
after the radio frequency (RF) pulse;   is the gyromagnetic ratio;   ( ) is the field 
inhomogeneity;  ( ) is the imaging field gradient at time      . When flow 
exists, the position vector   of the excited spins depends on t and should be noted 
as  ( ). The signal equation becomes: 
 
 ( )  ∫ ( ( ))   (   ∫   ( ( ))  
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 ∫ ( ( ))             
[5.2] 
The first phase term       ∫   ( ( ))  
 
 
 represents the phase that a spin 
isochromat accumulates along the traveling path in image space. The second phase 
term     ∫  ( )
 
 
  ( )   contains the usual k-space encoding. Let us assume 
that for a given spatial location r, the velocity  ( ( )) is constant in a local region 
around r and is constant in time, up to at least the largest TE. Then  ( )     
 (  )       (  )(    ), where     ( ) and      (  ). Let us further 
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assume   ( ) is linearly varying in a small local region around the path of the 
moving spin, i.e.,   (    )    ( )     ( )    . After substituting  ( ) into 
Eq [5.2],    and    becomes: 
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[5.4] 
where  (  ) is the k-space position and  (  ) is the first moment of  ( ) at 
time TE. In Eq [5.3], the phase    is a quadratic function of TE. The linear 
coefficient reflects the local field inhomogeneity, causing shift along the readout 
direction; The quadratic coefficient is proportional to the flow velocity and the 
gradient of the field inhomogeneity, referred to here as the inhomogeneity field 
gradient. This quadratic phase term is independent of phase encoding and its TE 
squared dependence may cause blurring along the readout direction. In Eq [5.4], the 
second term can be compensated using gradient moment nulling for a given imaging 
gradient as in standard MRA (62,91-96). 
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5.2.2 Gradient moment nulling 
A diagram of the 3D multi-echo GRE sequence with first moment nulling gradient is 
illustrated in Figure 5.1.  
 
Figure 5.1 Flow compensated multi-echo GRE sequence 
Bipolar flow compensation gradients (shaded in gray) are added before each echo in 
the phase and slice encoding directions to null the first order gradient moment. 
The fully flow compensation can be realized using the following gradient constraints 
(    at the peak of the RF,       at the nth echo center): 
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In the readout direction, each echo is refocused, and flow compensation is naturally 
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achieved at the center of each echo after inserting an appropriate moment nulling 
gradient before the first echo. In the phase encoding directions (   and   ), the first 
moment of phase encoding gradient increases from one echo to the next by the amount 
of the phase encoding gradient area (   or   ) times the echo spacing, so the same 
gradient moment nulling can be used for all later echoes except the first one.  
Gradient moment nulling removes the extra phase   (  )   (  ) for each TE in 
a multi-echo sequence. Note that gradient moment nulling only corrects for the 
ghosting artifacts in the magnitude images. The reconstructed image still has an extra 
phase component 
 
 
  (  )     (   )  
  due to the varying local field in which the 
moving spins travel.  
5.2.3 High order fit of the multi-echo phase 
In image space, and under the assumptions stated above, phase is a linear or quadratic 
function of TE depending on whether or not the spin is traveling. A linear fit is 
applicable in static regions but a quadratic fit may be necessary in voxels experiencing 
flow. In this study, both a linear fit           and a quadratic fit     
  
              were performed for each voxel. However, there is much greater 
noise amplification in the quadratic fit than the linear fit due to the increased 
unknowns. In order to improve the SNR, a mixing of linear and quadratic fits, referred 
to as adaptive-quadratic fit, was developed to ensure that the quadratic fit was only 
used in regions with flow. As indicated in Eq [5.3], the field inhomogeneity     is 
the coefficient of the linear term   or   . In flow regions,   and    are distinctly 
different and    is nonzero. Based on this, the field inhomogeneity was computed as 
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the combination of the two fit results:     (   )     , using the weighting 
       |(   
 )  |    , with empirical       . The resulting field 
inhomogeneity map served as the input for nonlinear morphology enabled dipole 
inversion (83), a dipole deconvolution solver, to compute the susceptibility map. 
5.3 Flow Phantom Experiment 
5.3.1 Phantom setup 
A U-shaped vinyl tube connected to a pump was fixed inside a plastic box, which was 
filled with tap water and put inside the scanner. The pump generated a constant flow 
with known velocity. Both experiments were performed on a 3T scanner (GE Signa 
HDxt). 
5.3.2 Flow displacement  
In the first experiment, two scans were performed: the first scan with an unmodified 
product sequence where flow compensation was only applied to  the readout 
direction (10 echoes, TR/TEfirst/TElast =36.0/3.1/32.2ms, FA=20˚, coronal FOV=25cm, 
voxel size = 1×1×1 mm
3
, BW=±62.5kHz) and the second scan with the proposed 
sequence with flow compensation applied in all three directions for all echoes (6 
echoes, TR/TEfirst/TElast =35.0/3.1/30.3ms, FA=20˚, coronal FOV= 25cm, voxel size = 
1×1×1 mm
3
). The flow velocity was set to 60cm/s to match the magnitude of quadratic 
term component       to that observed in preliminary in vivo studies. 
Figure 5.2 shows the magnitude images acquired without (Figure 5.2a) and with 
(Figure 5.2b) phase encoding flow compensation (i.e.    and   ). In Figure 5.2a, 
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without flow compensation, displacement artifacts appear in the phase encoding 
direction, which increase with TE. In Figure 5.2b, it can be seen that flow 
compensation markedly reduces these artifacts. 
 
Figure 5.2 Magnitude from scans with/without flow compensation 
Shown are images at TE=12ms and 29ms. Without flow compensation, water flow 
displacement artifacts appear in the phase encoding direction, which increase with TE. 
With flow compensation, the artifacts are substantially reduced. 
Figure 5.3 shows the phase plot of one voxel indicated by the arrow in Figure 5.2. 
In Figure 5.3a, due to displacement of the flow, the phase from non-compensated scan 
exhibits a nonlinear relationship with TE. In Figure 5.3b, although with flow 
compensation, the phase exhibits an approximately quadratic, instead of linear, 
relationship as a function of TE. The absolute value of the linear coefficient – 
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presumed to be proportional to the field inhomogeneity – is 12 times larger for the 
linear fit (-0.0695) as compared to the quadratic fit (-0.0057). 
 
Figure 5.3 Phase plot from scans with/without flow compensation 
The phase measured in the later echoes no longer reflects the phase of the original 
voxel due to its flow-induced displacement. The phase of the same voxel exhibits an 
approximately quadratic relationship because of the susceptibility induced field 
gradient. The absolute value of the linear coefficient of the linear fit (-0.0695) is 12 
times larger than that of the quadratic fit (-0.0057), 
5.3.3 QSM of flow with contrast agent 
The above flow scan with flow compensation was repeated a number of times. Each 
time, the tap water inside the tube was replaced with a gadopentetate dimeglumine 
(Gd-DTPA, Magnevist, Bayer HealthCare) solution with different concentrations. 
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Two QSM images were reconstructed, one with a linear and one with an adaptive-
quadratic fitted field map. The measured susceptibility was compared with that from 
the reference QSM images reconstructed from a scan without flow. 
 
Figure 5.4 QSM of flow with contrast agent 
(a) Error map of reconstructed susceptibility of flowing contrast agent solution at a 
velocity of 60 cm/s. Data was acquired with the fully flow compensated sequence. The 
reconstruction error using the adaptive-quadratic fit was markedly reduced compared 
to that using the linear fit, especially in regions pointed to by ROI1 and ROI2. (b) 
Linear regression of the measured susceptibility versus the reference susceptibility. 
Five experiments with different concentration of contrast agent solutions were 
performed. The reference susceptibility was obtained in the zero-flow state. The 
measured susceptibility was obtained  using both the linear and the adaptive-
quadratic fit at a flow rate of 60 cm/s. Compared with the linear fit, the adaptive-
quadratic fit exhibits more accurate measurement over all concentrations with a 
regression slope close to 1. 
Figure 5.4a shows the QSM error image of the flowing contrast agent solution. 
Linear Adaptive quadratic
-0.2 ppm
0.2 ppm
a
b
ROI 1 ROI 2 ROI 1 ROI 2
y = 1.12x - 0.01
y = 0.82x - 0.06
0
0.3
0.6
0.9
1.2
0 0.3 0.6 0.9 1.2
M
e
as
u
re
d
 s
u
sc
e
p
ti
b
ili
ty
 (
p
p
m
)
Li
n
e
ar
 f
it
Reference susceptibility (ppm)
ROI 1
ROI 2
y = 1.02x - 0.02
y = 1.05x - 0.09
0
0.3
0.6
0.9
1.2
0 0.3 0.6 0.9 1.2
M
e
as
u
re
d
 s
u
sc
e
p
ti
b
ili
ty
 (
p
p
m
)
A
d
ap
ti
ve
 q
u
ad
ra
ti
c 
fi
t
Reference susceptibility (ppm)
ROI 1
ROI 2
 85 
The error image was obtained by subtracting the reference QSM acquired during zero 
flow from the QSM acquired during non-zero flow. Inside the tube, the error of the 
adaptive-quadratic fit was markedly reduced compared with that from the linear fit, 
especially in the two ROI regions. Figure 5.4b shows the linear regression of the 
measured susceptibility versus the reference susceptibility for five distinct contrast 
agent solutions. In both ROIs, adaptive-quadratic fit exhibits more accurate 
measurement compared with linear fit over all the concentrations. 
5.3.4 Flow velocity measurement  
A second flow experiment was performed to validate the polynomial phase expansion 
in Eq [5.3]. For a given flow velocity, two data sets were acquired for two different Z 
shimming gradient to create a magnetic field that varies linearly along the B0 
direction. The Z direction was chosen because it coincides with the principal direction 
of the flow in the straight parts of the U shaped tube. A quadratic fit was performed 
for each of the two acquisitions obtaining       ( )    ( )    ( )   
  ( )  
  and       ( )    ( )    ( )     ( )  
 . Then, the following 
holds: 
 
  ( )    ( )   
 
 
  ( )   (   ( )     ( )) 
  
 
 
  ( )  (  ( )    ( ))    
[5.5] 
where    and    are the total magnetic field of the two scans. In this equation, we 
have used the fact that the difference between    and    is induced by the 
difference in the Z shim, such that the assumption of a spatially linearly varying field 
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in Eq [5.3] is satisfied. Then, the flow velocity along Z can then be obtained as 
follows: 
 
  ( )    (  ( )    ( )) ( (  ( )    ( ))   ) [5.6] 
The acquisition of the two data sets with differing Z shimming was repeated for a 
range of flow velocities between 28cm/s to 62cm/s. For each of the velocities, these 
two acquisitions were performed (Z shim difference 1400Hz/m) as well as a 2D phase 
contrast scan (TR/TE = 15/6ms, FA=10˚, FOV=25cm, matrix size = 256×128, slice 
thickness = 5mm, BW=±15.63kHz, VENC=100cm/s, using an acquisition plane 
orthogonal to the straight parts of the U shaped vinyl tube). 
 
Figure 5.5 Quantification of flow velocity 
(a) A representative Z direction flow velocity map computed based on the theory. Two 
data sets are acquired, which are identical except for a different Z shim gradient. The 
coefficients of the quadratic fit are used to obtain this velocity map. The estimated 
flow has opposite signs on the two straight sections, as expected. (b) Linear regression 
of the measured flow velocity versus the reference flow velocity at six velocity 
settings.  The obtained regression slope is 1.1 and R
2
 is 0.99, indicating a good 
agreement of the measured velocity. The reference flow velocity was obtained using a 
separate phase contrast acquisition for each flow setting. 
Figure 5.5a is the Z direction velocity map derived from the second order fit 
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coefficient of the two scans with varying Z shim gradients. Opposite signs of velocity 
were observed on the two sides of the U shaped tube as the flow changes signs in the 
Z direction. The velocity in the selected ROI (see Figure 5.5a) was measured in six 
experiments with varying flow, which was then compared with the reference velocity 
measured with a phase contrast scan as shown in Figure 5.5b. Good agreement was 
found between the two measurements, with a linear regression slope of 1.1 and R
2
 of 
0.99. 
5.4 In Vivo Study 
5.4.1 Scan protocol 
This study was institutional review board approved and HIPPA-compliant. In N = 8 
healthy volunteers (7 male, 1 female), the brain was imaged using an 8-channel head 
coil on a 3T scanner (GE Healthcare) after obtaining informed consent. Typical scan 
parameters were: axial scan, 7 echoes, TR/TEfirst/TElast =48.2/3.7/43.8ms, FA=20˚, 
FOV =24cm, voxel size = 0.7×0.7×0.7mm
3
, BW=±62.5kHz. All volunteers were 
scanned using the proposed fully flow compensated sequence. 
5.4.2 Vein visualization 
Both a linear fit and the proposed adaptive-quadratic fit were used to obtain a field 
map. Two QSM images were reconstructed using the respective field maps. Major 
veins were identified by an experienced reader in a Maximal Intensity Projections 
(MIPs) of a 15mm thick volume centered at the location of the boundary between the 
two hemispheres. The number of visualized cortical veins longer than 1cm was 
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compared between the two reconstructions. 
Figure 5.6 shows QSM MIPs of a 15 mm-thick sagittal slab centered at the 
location of the boundary between the two hemispheres. Both linear fit and adaptive-
quadratic fit results are shown here. The adaptive-quadratic fit reconstruction greatly 
improves vessel appearance, especially in cortical veins. A number of small veins 
missing in the linear fit QSM were recovered by the adaptive-quadratic fit method. 
Some veins that appeared disjointed in the linear fit QSM were better visualized using 
the adaptive-quadratic fit. The conspicuity and the sharpness of a number of dim veins 
were improved. 
 
Figure 5.6 MIP of brain susceptibility map 
MIPs from linear (a) and adaptive-quadratic (b) fit QSM shows the improvement of 
the vessel depiction using the adaptive-quadratic fit. Dim and apparently disconnected 
veins from the linear fit result are better visualized using the adaptive-quadratic fit. 
In all 8 volunteers, more cortical veins were visualized in the adaptive-quadratic fit 
QSM. Figure 5c shows the number of cortical veins visualized within the 15 mm 
sagittal MIP in each volunteer. For all cases, more cortical veins were observed and 
the percentage increase from adaptive-quadratic fit QSM is 37.3%±14.9% (p<0.001). 
Linear
Adaptive 
quadratic 
a b
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Figure 5.7 Count of cortical veins 
Quantitative comparison of visualized cortical veins. In all subject, 37.3%±14.9% 
more cortical veins are visualized using the adaptive-quadratic fit. 
5.4.3 Oxygenation quantification 
Venous oxygen saturation SvO2 was computed using            (  
    )     (88). Hematocrit (Hct) was assumed to be 0.4 and the susceptibility 
difference between fully deoxygenated blood and oxygenated blood      was 
assumed to be 3.43ppm (62,86,97). Here        was the measured susceptibility 
value on the QSM images. In each volunteer, a number of estimates of SvO2 were 
obtained by taking the mean over an ROI in each of the six largest cortical veins 
identified above using both the linear and adaptive-quadratic fit. Next, for each 
volunteer, the average and standard deviation of these six SvO2 estimates were 
computed and compared between the two fitting models. The mean SvO2 across all 
selected cortical veins and all volunteers was also computed and compared. All 
comparisons were analyzed statistically using pair-wise two-tailed t-tests with a p-
value of 0.05 indicating statistical significance. 
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The average venous oxygen saturation of six cortical veins based on the 
susceptibility map is shown in Figure 5.8. The mean measured SvO2 value across all 
volunteers is 72.2%±4.1% for the adaptive-quadratic fit method and 93.1%±5.3% for 
the linear fit (p<0.001). Previous studies measured the SvO2 in a range of 50% to 75% 
(98-100). Thus, the mean SvO2 value from the adaptive-quadratic fit QSM falls within 
this range while that of the linear fit QSM would appear to lead to overestimation. For 
each volunteer, the error bar indicated the standard deviation of SvO2 value over the 6 
cortical veins used for measuring. The standard deviations for the linear fit method 
ranged from 5% to 17%, compared to those of the adaptive-quadratic fit, which ranged 
from 3% to 6%. 
 
Figure 5.8 Oxygenation level comparison 
The measured venous oxygen saturation (SvO2) from both the linear and adaptive-
quadratic fit QSM in all volunteers. Arrows indicate the veins on which the 
measurements were performed. The value is 72.2%±4.1% for the adaptive-quadratic 
fit method and 93.1%±5.4% for the linear fit method. The SvO2 variance over the six 
cortical veins for ROI analysis for each subject is also smaller for the adaptive-
quadratic fit QSM (3%-6%) compared with the linear fit QSM (5%-17%). 
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5.5 Discussion 
The preliminary results in this study suggest that flow compensation by nulling the 
gradient moment and modeling the flow phase under the gradient of the 
inhomogeneity field can reduce flow artifacts in image and improve the accuracy of 
mapping of in-vivo venous blood susceptibility. The flow artifacts in both image 
magnitude and phase from multi-echo GRE acquisition are markedly reduced by flow 
compensation. This flow compensated quantitative susceptibility mapping (QSM) 
method may provide a robust measurement of venous oxygen saturation in the brain, 
as the blood susceptibility is deoxyhemoglobin concentration times the molar 
susceptibility of deoxyhemoglobin. Previous approaches to MRI measurements of 
venous oxygen saturation rely on various assumptions on susceptibility distributions 
including distribution geometries (65,87,98-105). QSM has the potential to overcome 
these limitations and errors associated with these assumptions. Flow compensation 
using imaging gradient moment nulling and inhomogeneity field gradient phase 
modeling was shown to increase consistency in the estimation of paramagnetic 
deoxyhemoglobin concentration. 
The accumulated phase of proton spin isochromats is determined by the magnetic 
field they experience. This field may include a spatial gradient term consisting of 
imaging gradient used for spatial encoding or inhomogeneity field gradient induced by 
susceptibility sources. The imaging gradient is spatially uniform with magnitude as 
high as tens of mT/m. The inhomogeneity field gradient may be small and spatially 
varying, depending on the susceptibility strength and distribution. In the presence of a 
field gradient, the phase of moving spins is a polynomial function of time, quadratic 
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for constant flow, as well-known in phase contrast MRA. The nonlinear phase–time 
relationship can cause erroneous k-space encoding and may lead to vessel 
displacement in the phase encoding direction and blurring in the readout direction. In a 
multi-echo acquisition, this flow-induced displacement increases with TE and needs to 
be compensated for consistent voxel fitting across echoes. Flow compensation can be 
achieved using gradient moment nulling. In this study, we added bipolar flow 
compensation gradients in both phase encoding directions before each echo. The 
maximum TE was kept approximately unchanged. Since the addition of the 
compensation gradients increased the minimal echo spacing, this meant that the total 
number of echoes was reduced. To see the effect of the lower number of echoes on the 
resulting field map, the variance of the fitted field frequency   can be computed 
according to (106):  
 
  ( )    
∑  
 
(∑   )(∑     
 )  (∑     ) 
 [5.7] 
where   is the noise level of the complex echo images and      
 
  
  
 
 is the 
magnitude for the i-th echo. Assuming a constant noise level  , TEmin=4ms, 
TEmax=44ms and T2*=50ms (107) , reducing the number of echoes from 11 to 7 (as 
used in this study),  ( ) increases by 20%, leading to a decreased signal to noise for 
the estimated field frequency  . 
The gradient of the tissue induced inhomogeneity field, although typically much 
smaller than the imaging gradient, also needs to be considered in multiple echo 
sequences that include long TEs. This inhomogeneity field gradient may vary in space 
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with unknown magnitude, making it difficult to be compensated. Consequently, it may 
cause not only image blurring along the readout direction (dephasing effects on high 
   components) but also quantitative error in phase measurement (phase shift at 
  =0), the quadratic phase–time relationship in Eq [5.3].  
The quadratic relationship induced by flow and the inhomogeneity field gradient 
was demonstrated in the phantom experiment. From Eq [5.3], a linear fit of the phase 
  will lead to an underestimation of the field when         or to an 
overestimation of the field when        . For the phantom study, the field in ROI 
1 decreases along the flow direction, leading to         consistent with the 
overestimation of the field and susceptibility in Figure 5.4b (solid triangles). However, 
in ROI 2, the field increases along the flow direction, leading to        , 
consistent with the underestimation of the field and susceptibility in Figure 5.4 
(hollow triangles). The difference in field estimates between the linear and the 
adaptive fit can be quite substantial as shown in Figure 5.3b. By fitting the phase data 
with inclusion of the flow-induced quadratic term, the susceptibility map (Figure 5.4a) 
was improved. In the in vivo brain study, the condition       > 0 was also 
observed for the cortical veins where SvO2 was measured, leading to an 
underestimation of the field and the venous susceptibility. This resulted in oxygen 
saturation values higher than the range of values reported in the literature (Figure 5.8). 
The susceptibility map quality improves using the quadratic fit (Figure 5.6), and 
correspondingly the mean estimated oxygen saturation falls within that range (Figure 
5.8). The mean SvO2 value of 72.2% is consistent with a previous study (105) 
conducted by Fan et al., using a linear fit of the phase data, provided a value for ∆do 
 94 
of 0.27 ppm (cgs units, or 3.43 ppm in SI units) is used, as discussed by the authors of 
that study. This value for ∆do is consistent with experimentally obtained estimates. 
Performing QSM with the adaptive-quadratic fit can also eliminate the need to restrict 
the measurement of SvO2 to those vessels whose phase evolution is sufficiently linear 
in TE, as done in (105). 
In this work, we derived and applied a quadratic fit in the vessel voxels assuming a 
locally constant flow and a linearly varying field inhomogeneity in one TR interval. A 
non-constant (pulsatile) flow may exist in the vessels and higher order spatial 
variations may exist in the inhomogeneity field, resulting in higher order terms to the 
phase–time relationship. When these terms become substantial, a higher order 
polynomial fit is needed and can be easily incorporated into the approach outlined 
here. As the number of fit parameter increases, the noise of the fitted parameter also 
increases. To maintain a high SNR in the estimated parameters, we may desire the 
linear fit for voxels known of having no flow. Automated image segmentation of 
regions of no flow is a difficult mathematical problem. Instead, we adopted an 
empirical weighted average of both linear and quadratic fits using a weighting 
determined by the magnitude of the second order coefficient for the quadratic fit (an 
indication of the flow magnitude) and the difference between the linear coefficients of 
the two fits (another indication for flow existence). Preliminary results here 
demonstrated the feasibility of this weighting scheme but it may be further improved. 
5.6 Conclusion 
By using a fully flow compensated multi-echo GRE sequence and an adaptive-
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quadratic fit of the phase images at all echoes, vessel visibility and susceptibility 
measurements are improved. This method significantly reduces the flow induced 
displacement artifacts and improves the field inhomogeneity estimation to ensure a 
more accurate dipole deconvolution for obtaining the susceptibility map. Improved 
vein susceptibility enables in-vivo measurement of venous oxygen saturation in the 
brain.
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CHAPTER 6  
FUTURE DIRECTIONS AND CONCLUSION 
6.1 Future Directions 
MRI always quest for fast and quantitative imaging technique. Spiral sampling and 
constrained reconstruction allows dynamic imaging but also brings artifacts. For 
dynamic MRI, it is desirable to have larger spatial coverage, higher spatial and 
temporal resolution or to increase temporal resolution. Future research continuing this 
dissertation involves reducing artifacts, improving motion robustness, and further 
increasing spatial-temporal resolution. The dynamic imaging technique can also be 
adjusted to fit in other clinical applications. 
6.1.1 Artifacts reduction 
Spiral sampling and constrained reconstruction poses artifacts that need further 
investigation. Specifically the following areas should be looked into. 
First is to reduce spiral under-sampling artifacts. TRACER reconstruction employs 
highly under-sampled spiral to update the temporal information. The under-sampling 
artifacts are not apparent in a single frame but appear as temporal signal fluctuation 
across image time series, when imposing strong prior information constraints. One 
way to eliminate this artifact is to smooth the signal time curves in post-processing. 
Another way is to impose temporal constraints, such as the second order derivative of 
time curves in the solving process. In either case, both the temporal changes and the 
spatial correlation should be taken into account. 
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Second is to reduce spiral off-resonance artifacts, appearing as blurred image 
edges. Off-resonance correction requires a field map, which is readily available in a 
multi-echo acquisition. There are time-segmented and frequency-segmented off-
resonance correction scheme in fully sampled dataset. Integrating them with dynamic 
imaging especially high under-sampled spiral imaging needs further development. 
Correction of the spiral sampling trajectory is another area worth looking into. 
Imperfect gradient field results in k-space sampling trajectory away from prescription, 
showing as intensity variation across the image. This imperfection is manifested in 
multi-echo scans when the TR is long. Incorporating trajectory mapping can 
potentially improve the image quality and quantitation accuracy for dynamic QSM 
study. 
6.1.2 Spatial-temporal resolution improvement 
A major improvement would be to further increase the spatial-temporal resolution of 
TRACER. In the developed cerebral perfusion MRI, the spatial coverage is limited by 
the temporal resolution of multi-echo acquisition. Further acceleration could be 
achieved through parallel imaging in slice encoding direction. This could be readily 
done with segmented slice encoding view order. Each under-sampled slice segment is 
used to reconstruct a time frame and served as the initial guess for the next segment. 
The acceleration rate would be the same as the number of segments. Another area 
worth looking into is true 3D spiral or radial sampling trajectory. These sampling 
strategies incorporate true 3D k-space coverage in one TR. Consecutive TRs will 
contain k-space information that is much more incoherent than a stack-of-spiral scan. 
This allows further temporal resolution improvement as the temporal resolution is not 
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restricted by a fully sampled slice encoding in stack-of-spiral scan. More uniform k-
space coverage may reduce the under-sampling artifacts in TRACER. 
Another way to improve the temporal resolution is to incorporate global 
information in the minimization solver. The TRACER algorithm relies on prior 
information from previous frames. The acquired data in later frames could also serve 
as prior information. They can be all combined as one 4D data set for global 
minimization. This may need initial guess from a sliding window reconstruction and 
the initial guess could be modified locally to predict the temporal behavior for 
improved temporal tracking. 
6.1.3 Motion correction 
Respiratory motion induces liver position changes. In liver perfusion imaging, the 
motion needs to be corrected for reliable contrast enhancement curve measurement. 
Due to respiratory motion, a lesion can move out of an ROI, resulting in meaningless 
measurement. Correction of motion can be integrated into the reconstruction process. 
A displacement field can be computed along with TRACER by registering consecutive 
frames. This displacement is formed as an additional term in the minimization 
problem, forcing the liver to stay still. The structures of an artifact free liver image at 
the beginning of the scan can also be used to constrain motion corrupted data. The 
other direction of motion correction is to post-process enhancement curves from 
motion corrupted TRACER reconstruction. The selected ROI is allowed to move in a 
3D neighborhood to track the tissue. Then the temporal curves is also constrained to 
be smooth and with limited amount temporal basis functions to reduce the search 
space. 
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6.1.4 Exploration of application 
Multi-echo spiral acquisitions can be used in liver QSM. Liver imaging with breath 
hold requires acquisition time less than 30 seconds in clinical studies. Spiral sampling 
provides the opportunity to complete a QSM scan in one breath hold. This enables 
absolute quantification of iron deposition in liver which is a biomarker in liver 
examination. The oxygenation in portal vein, hepatic artery and hepatic veins can also 
be quantified to study liver function. Due to the existence of lungs, stomach and fat, 
good segmentation of liver and field estimation without fat effect would be desired in 
liver QSM. 
Another application is to use dual-echo spiral acquisition with TRACER 
reconstruction dynamic for liver MRA. The current DCE liver perfusion requires fat 
suppression. Fat suppression is often affected due to deviation of fat off-resonance 
frequency from programed value, imperfect rf pulse or field inhomogeneity. Dual-
echo acquisition with a TE different close to 2ms can produce two datasets with a π 
phase different for water-fat separation using two-point Dixon method. The water 
image from this reconstruction will have an improved CNR of vessels compared with 
traditional fat-suppression method. 
6.2 Conclusion 
In this dissertation, three imaging techniques were developed to quantify tissue 
perfusion and oxygenation. The liver perfusion technique achieves sub-second 
temporal resolution with high spatial resolution and coverage. It has been routinely 
used in our hospital as a clinical protocol. The dynamic QSM method allows direction 
 100 
contrast agent quantification. It avoids assumptions in R2* based method, promises to 
produce improved contrast agent quantification. The proposed flow compensation and 
quadratic fitting resolves flow issues in QSM and provides a method for in vivo blood 
oxygenation quantification. 
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